TWI354843B - Liquid crystal alignment agent and liquid crystal - Google Patents

Liquid crystal alignment agent and liquid crystal Download PDF

Info

Publication number
TWI354843B
TWI354843B TW096135644A TW96135644A TWI354843B TW I354843 B TWI354843 B TW I354843B TW 096135644 A TW096135644 A TW 096135644A TW 96135644 A TW96135644 A TW 96135644A TW I354843 B TWI354843 B TW I354843B
Authority
TW
Taiwan
Prior art keywords
liquid crystal
group
hydrogen atom
crystal alignment
alignment agent
Prior art date
Application number
TW096135644A
Other languages
Chinese (zh)
Other versions
TW200821716A (en
Inventor
Hiroyuki Yasuda
Eiji Hayashi
Michinori Nishikawa
Original Assignee
Jsr Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jsr Corp filed Critical Jsr Corp
Publication of TW200821716A publication Critical patent/TW200821716A/en
Application granted granted Critical
Publication of TWI354843B publication Critical patent/TWI354843B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/52Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
    • C09K19/54Additives having no specific mesophase characterised by their chemical composition
    • C09K19/56Aligning agents
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/10Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L79/00Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing nitrogen with or without oxygen or carbon only, not provided for in groups C08L61/00 - C08L77/00
    • C08L79/02Polyamines
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L79/00Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing nitrogen with or without oxygen or carbon only, not provided for in groups C08L61/00 - C08L77/00
    • C08L79/04Polycondensates having nitrogen-containing heterocyclic rings in the main chain; Polyhydrazides; Polyamide acids or similar polyimide precursors
    • C08L79/08Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1337Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
    • G02F1/133711Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by organic films, e.g. polymeric films
    • G02F1/133723Polyimide, polyamide-imide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Health & Medical Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nonlinear Science (AREA)
  • Mathematical Physics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Liquid Crystal (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)

Description

1354843 九、發明說明: 【發明所屬之技術領域】 本發明涉及液晶配向劑和液晶顯示元件。更具體地 說,涉及能夠形成電性能良好且印刷性良好的液晶配向膜 的液晶配向劑以及含有該液晶配向膜的液晶顯示元件。 【先前技術】 目前,作爲液晶顯示元件,已知具有所謂TN(Twisted Nematic)型液晶胞的TN型液晶顯示元件,其在設置了透明 導電膜的基板表面上形成由聚醯胺酸、聚醯亞胺等形成的 液晶配向膜,作.爲液晶顯示元件用的基板,將該2片基板 相對設置,在其間隙內形成具有正介電各向異性的向列型 液晶層,構成夾層結構的晶胞,液晶分子的長軸從一片基 板向另一片基板連續地扭轉90度。並且,還開發了與TN 型液晶顯示元件相比對比度更高、其視角依賴性更小的 STN(Super Twisted Nematic)型液晶顯示元件和垂直配向型 液晶顯示元件。該STN型液晶顯示元件將在向列型液晶中 摻合了作爲光學活性物質的手性劑的液晶作爲液晶使用, 其利用通過使液晶分子的長軸在基板間處於連續扭轉180 度以上幅度的狀態而產生的雙折射效果。相比之下,如非 專利文獻1和專利文獻1所述,提出了在I TO上形成突起 來控制液晶配向方向的被稱作爲MVA方式的垂直配向型液 晶顯示元件。Μ V A方式之液晶顯示元件不僅視角、對比度 等優良,而且在形成液晶配向膜的過程中還可以不進行 打磨處理等,因而在製程方面也是優良的。作爲適用於 1354843 ΤΝ、STN、MVA方式的液晶配向膜,被要求液晶顯示元件 的殘像消除時間短等性能。另外,作爲形成該等液晶配向 膜所用的配向劑,被要求在平版印刷中具有優良的印刷性。 【非專利文獻1】“液晶” Vol· 3 No· 2 117(1999年) 【專利文獻1】日本特開平1 1 - 258605號公報 【發明內容】 本發明是鑒於上述問題而作出的,其目的是提供能夠 形成在維持電壓保持率的同時又使蓄積電荷減少的液晶配 向膜’並且具有優良的印刷性的液晶配向劑以及使用該液 晶配向膜的液晶顯示元件。 本發明的其他目的和優點可以由以下的說明看出。 根據本發明,本發明的上述目的和優點,第一,由一 種液晶配向劑達成,其特徵在於含有下述式(I)表示的化合 物(以下,也稱爲特定化合物),1354843 IX. Description of the Invention: [Technical Field] The present invention relates to a liquid crystal alignment agent and a liquid crystal display element. More specifically, it relates to a liquid crystal alignment agent capable of forming a liquid crystal alignment film having good electrical properties and excellent printability, and a liquid crystal display element containing the liquid crystal alignment film. [Prior Art] At present, as a liquid crystal display element, a TN type liquid crystal display element having a so-called TN (Twisted Nematic) type liquid crystal cell is known, which is formed of polylysine, polyfluorene on the surface of a substrate provided with a transparent conductive film. A liquid crystal alignment film formed of an imide or the like is used as a substrate for a liquid crystal display element, and the two substrates are opposed to each other, and a nematic liquid crystal layer having positive dielectric anisotropy is formed in the gap to form a sandwich structure. The unit cell, the long axis of the liquid crystal molecules is continuously twisted by 90 degrees from one substrate to the other substrate. Further, STN (Super Twisted Nematic) type liquid crystal display elements and vertical alignment type liquid crystal display elements having higher contrast and smaller viewing angle dependence than TN type liquid crystal display elements have been developed. The STN type liquid crystal display element uses a liquid crystal in which a chiral agent as an optically active substance is blended in a nematic liquid crystal as a liquid crystal by using a long axis of liquid crystal molecules to be continuously twisted by 180 degrees or more between substrates. The birefringence effect produced by the state. In contrast, as described in Non-Patent Document 1 and Patent Document 1, a vertical alignment type liquid crystal display element called an MVA method in which protrusions are formed on I TO to control the alignment direction of liquid crystals has been proposed. The liquid crystal display element of the V A type is excellent not only in viewing angle and contrast, but also in the process of forming the liquid crystal alignment film, and is also excellent in the process. As a liquid crystal alignment film suitable for the 1354843 ΤΝ, STN, and MVA systems, it is required that the residual image erasing time of the liquid crystal display element is short. Further, as an alignment agent for forming the liquid crystal alignment films, it is required to have excellent printability in lithography. [Non-Patent Document 1] "Liquid Crystal" Vol. 3 No. 2, 117 (Patent Document 1) [Patent Document 1] Japanese Laid-Open Patent Publication No. Hei No. Hei. No. Hei. It is a liquid crystal alignment agent which can form a liquid crystal alignment film which maintains a voltage holding ratio and reduces an accumulated electric charge, and has excellent printability, and a liquid crystal display element using the liquid crystal alignment film. Other objects and advantages of the invention will be apparent from the description which follows. According to the present invention, the above objects and advantages of the present invention are attained by a liquid crystal alignment agent characterized by containing a compound represented by the following formula (I) (hereinafter, also referred to as a specific compound).

(式中之R,〜R8各自獨立地爲氫原子、烷基或烷氧基, R9〜R12各自獨立地爲氫原子、芳香族基團或脂肪族基團, A爲氫原子或脂肪族基團,η爲1〜100的整數)。 上述式(I)中,下述的化合物是較佳的化合物,1〜118 1354843 各自獨立地爲氫原子、碳數爲1〜6的烷基或者碳數爲1〜6 的烷氧基,R9〜RI2均爲氫原子,A爲氫原子,η爲1〜100 的整數。 上述式(I)中,下述的化合物是另一些較佳的化合物, R,〜R8各自獨立地爲氫原子、碳數爲1〜6的烷基或者碳數 爲1〜6的烷氧基,R9和Rh爲芳香族基團,R,。和Rl2爲氫 原子或脂肪族基團,A爲氫原子或脂肪族基團,η爲1〜1〇〇 的整數。 另外,上述式(I)中,下述的化合物是更佳的化合物, R,〜R8各自獨立地爲氫原子、碳數爲1〜6的烷基或者碳數 爲1〜6的院氧基,R9和Ru爲芳香族基團,Ri。和Riz爲氫 或含環氧基的脂肪族基團,A爲氫原子或含環氧基的脂肪 族基團,η爲1〜100的整數。 根據本發明,本發明的上述目的和優點,第二,由一 種液晶配向劑達成,其特徵在於含有由上述式(I)中之R,〜 R8各自獨立地爲氫原子、碳數爲1〜6的烷基或者碳數爲1 〜6的烷氧基,R9〜Ru均爲氫原子,A爲氫原子,η爲1〜 100的整數的上述較佳的化合物與四羧酸二酸酐反應所得 的聚醯胺酸聚合物(以下也稱爲特定聚醯胺酸聚合物)。 另外,本發明的液晶配向劑還可以含有上述特定化合 物和上述特定聚醯胺酸聚合物中的至少一種以及從由下述 式(I 一 1)表示的重複單元所構成的聚醯胺酸和由(1-2)表 示的重複單元所構成的聚醯亞胺構成的群組中選出的至少 1354843 種聚合物 • · . (1-1) HOOC、 COOH HNOC’、CONH —Q1-(wherein R, R8 are each independently a hydrogen atom, an alkyl group or an alkoxy group, and R9 to R12 are each independently a hydrogen atom, an aromatic group or an aliphatic group, and A is a hydrogen atom or an aliphatic group. Group, η is an integer from 1 to 100). In the above formula (I), the following compounds are preferred compounds, and 1 to 118 1354843 are each independently a hydrogen atom, an alkyl group having 1 to 6 carbon atoms or an alkoxy group having 1 to 6 carbon atoms, R9. RI2 is a hydrogen atom, A is a hydrogen atom, and η is an integer of 1 to 100. In the above formula (I), the following compounds are other preferred compounds, and R, R8 are each independently a hydrogen atom, an alkyl group having 1 to 6 carbon atoms or an alkoxy group having 1 to 6 carbon atoms. , R9 and Rh are aromatic groups, R,. And R12 is a hydrogen atom or an aliphatic group, A is a hydrogen atom or an aliphatic group, and η is an integer of 1 to 1 Å. Further, in the above formula (I), the following compound is a more preferable compound, and each of R and R8 is independently a hydrogen atom, an alkyl group having 1 to 6 carbon atoms or an alkoxy group having 1 to 6 carbon atoms. R9 and Ru are aromatic groups, Ri. And Riz is a hydrogen or an epoxy group-containing aliphatic group, A is a hydrogen atom or an epoxy group-containing aliphatic group, and η is an integer of from 1 to 100. According to the present invention, the above objects and advantages of the present invention, and secondly, are achieved by a liquid crystal alignment agent characterized in that R, R, R8 in the above formula (I) are each independently a hydrogen atom and have a carbon number of 1 to 1. 6 alkyl or an alkoxy group having 1 to 6 carbon atoms, R9 to Ru are each a hydrogen atom, A is a hydrogen atom, and η is an integer of 1 to 100, and the above preferred compound is reacted with tetracarboxylic acid dianhydride. Poly-proline polymer (hereinafter also referred to as a specific poly-proline polymer). Further, the liquid crystal alignment agent of the present invention may further contain at least one of the above specific compound and the above specific polyaminic acid polymer, and a polylysine composed of a repeating unit represented by the following formula (I-1) and At least 1354484 kinds of polymers selected from the group consisting of polyimine consisting of repeating units represented by (1-2) • (1-1) HOOC, COOH HNOC', CONH — Q1-

(其中,p2爲4價的有機基團,且Q2爲2價的有機基 團)。 【實施方式】 以下,對本發明進行更詳細地說明。 本發明的液晶配向劑較佳爲將特定化合物和特定聚醯 胺酸聚合物的至少一種’以及選自聚醯胺酸與聚醯亞胺的 至少一種聚合物溶於有機溶劑中而構成。 [特定化合物] 式(1)中’ Ri〜R8各自獨立地爲氫原子、烷基或者烷氧 基。烷基、烷氧基較佳爲碳數爲1〜6的烷基、碳數爲1〜6 1354843 的烷氧基。作爲這種烷基和烷氧基中所含的烷基,可以舉 例如甲基、乙基、正丙基、異丙基、正丁基、2-甲基-丙基、 3-甲基-丙基、正戊基、正己基。R9〜Rl2各自獨立地爲氫原 子、芳香族基團或者脂肪族基團。較佳爲氫原子、苯基、 萘基、碳數爲1〜4的脂肪族基團或者含環氧基的脂肪族基 團,具體地可以舉出甲基、乙基、丙基、丁基、縮水甘油 基。A較佳爲氫原子或碳數爲1〜4的脂肪族基團或含環氧 基的脂肪族基團,具體地可以舉出甲基、乙基、丙基、丁 基、縮水甘油基。並且,η爲1〜100的整數。 其中特佳爲Ri〜Rs爲氫,Rs〜R12各自獨立地爲氫原 子、甲基、乙基、苯基、縮水甘油基,A爲氫原子或縮水 甘油基。 作爲特定化合物,可以舉出以下化合物。(wherein p2 is a tetravalent organic group, and Q2 is a divalent organic group). [Embodiment] Hereinafter, the present invention will be described in more detail. The liquid crystal alignment agent of the present invention is preferably constituted by dissolving at least one of a specific compound and a specific polyamic acid polymer and at least one polymer selected from the group consisting of polyamic acid and polyimine in an organic solvent. [Specific compound] In the formula (1), ' Ri to R8 are each independently a hydrogen atom, an alkyl group or an alkoxy group. The alkyl group and the alkoxy group are preferably an alkyl group having 1 to 6 carbon atoms and an alkoxy group having 1 to 6 1354843 carbon atoms. The alkyl group contained in such an alkyl group and an alkoxy group may, for example, be a methyl group, an ethyl group, a n-propyl group, an isopropyl group, an n-butyl group, a 2-methyl-propyl group or a 3-methyl group. Propyl, n-pentyl, n-hexyl. R9 to Rl2 are each independently a hydrogen atom, an aromatic group or an aliphatic group. Preferred are a hydrogen atom, a phenyl group, a naphthyl group, an aliphatic group having 1 to 4 carbon atoms or an aliphatic group having an epoxy group, and specific examples thereof include a methyl group, an ethyl group, a propyl group and a butyl group. , glycidyl group. A is preferably a hydrogen atom or an aliphatic group having 1 to 4 carbon atoms or an aliphatic group containing an epoxy group, and specific examples thereof include a methyl group, an ethyl group, a propyl group, a butyl group, and a glycidyl group. Further, η is an integer of 1 to 100. Particularly preferably, Ri to Rs are hydrogen, and Rs to R12 are each independently a hydrogen atom, a methyl group, an ethyl group, a phenyl group or a glycidyl group, and A is a hydrogen atom or a glycidyl group. The following compounds are mentioned as a specific compound.

-10- 1354843-10- 1354843

13548431354843

上述特定化合物中,當r9〜r12均爲氫原子時,使其與 酸二酐反應可以製得特定聚醯胺酸聚合物。在合成該特定 聚醯胺酸聚合物時,作爲酸二酐,較佳的可以舉例如 1,2,3,4-環丁烷四羧酸二酸酐、1,3-二甲基-1,2,3,4-環丁烷四 羧酸二酸酐、2,3,5-三羧基環戊基醋酸二酸酐、 -12- 1354843 1,3,3a,4,5,9b-六氫- 5-(四氫-2,5-二氧代-3-呋喃基)-萘[1,2-c] 呋喃-1,3-二酮、順式-3,7-二丁基環辛-1,5-二烯-1,2,5,6-四 羧酸二酸酐、3,5,6-三羰基-2-羧基降冰片烷-2:3,5:6-二酸 酐、1,3,33,4,5,91)-六氫-8-甲基-5-(四氫-2,5-二氧代-3-呋喃 基)-萘[l,2-c]呋喃-1,3-二酮' 3-氧雜雙環[3.2.1]辛烷-2,4-二 酮-6-螺-3’ -(四氫呋喃-2’ ,5’ -二酮)、5-(2,5-二氧代四氫 -3-呋喃基)-3-甲基-3-環己烯-1,2-二羧酸酐、3,5,6-三羧基 -2-羧基降冰片烷-2:3,5:6-二酸酐、4,9-二氧雜三環 [5.3.1.02’6]十一烷- 3,5,8,10-四酮、均苯四酸二酸酐等。這些 酸二酐可以單獨或2種以上組合使用。 另外,這時,除了具有二胺結構的上述特定化合物以 外,還可以倂用其他二胺化合物。作爲較佳的其他二胺化 合物,可以舉例如對-苯二胺、4,4’ -二胺基二苯甲烷、4,4’ - 二胺基二苯硫醚、2,2’ -二甲基-4,4’ -二胺基聯苯、1,5-二 胺基萘、2,7-二胺基芴、9,9-二甲基-2,7-二胺基芴、4,4’ - 二胺基二苯基醚、2,2-二[4-(4-胺基苯氧基)苯基]丙烷、9,9-二(4-胺基苯基)芴、2,2-二[4-(4-胺基苯氧基)苯基]六氟丙 烷、2,2-二(4-胺基苯基)六氟丐烷、4,4’ -(對-伸苯基異亞丙 基)二苯胺、4,4’ -(間-伸苯基異亞丙基)二苯胺、1,4-環己 烷二胺、4,4’ -伸甲基二(環己胺)、1,4-二(4-胺基苯氧基) 苯、4,4’ -二(4-胺基苯氧基)聯苯、2,6-二胺基吡啶、3,4- 二胺基吡啶' 2,4-二胺基嘧啶、3,6-二胺基吖啶、3,6-二胺 基咔唑、N-甲基-3,6-二胺基咔唑、N-乙基-3,6-二胺基咔唑、 -13- 1354843 N-苯基-3,6-二胺基咔唑、N,N, _二(4·胺基苯基)·聯苯胺、 Ν,Ν’ -二(4-胺基苯基)_Ν,Ν,-二甲基-聯苯胺等。這些其他 —胺化合物可以單獨或2種以上組合使用。 [聚醯胺酸] <四羧酸二酸酐> 、在本發明中,作爲上述特定聚醯胺酸聚合物以外的上 述聚醯胺酸合成中所用的四羧酸二酸酐,較佳爲脂環式四 羧酸二酸酐。作爲脂環式四羧酸二酸酐,例如,可以舉出 1,2,3,4-環丁烷四羧酸二酸酐、1,2·二甲基-1,2,3,4-環丁烷四 羧酸二酸酐、1,3-二甲基-1,2,3,4-環丁烷四羧酸二酸酐、1,3-二氯-1,2,3,4-環丁烷四羧酸二酸酐、1,2,3,4-四甲基-1,2,3,4-環丁烷四羧酸二酸酐、1,2,3,4-環戊烷四羧酸二酸酐、 1,2,4,5·環己烷四羧酸二酸酐、3,3’ ,4,4’ -二環己基四羧酸 二酸酐 '順式-3,7-二丁基環辛-1,5-二烯-1,2,5,6-四羧酸二 酸酐、2,3,5-三羧基環戊基醋酸二酸酐、3,5,6_三羰基·2-羧 基降冰片烷-2:3,5:6-二酸酐、2,3,4,5-四氫呋喃四羧酸二酸 肝、l,3,3a,4,5,9b-六氫- 5- (四氣-2,5-二氧代-3-呋喃基)·萘 [l,2-c]-呋喃-1,3-二酮、1,3,33,4,5,91)-六氫-5-甲基-5-(四氫 _2,5-二氧代-3-呋喃基)-萘[l,2-c]-呋喃-1,3-二酮、 1,3,3&,4,5,91)-六氫-5-乙基-5-(四氫-2,5-二氧代-3-呋喃基)-荼[l,2-c] -呋喃-1,3 -二酮、l,3,3a,4,5,9b -六氫-7 -甲基- 5- (四 氣-2,5-二氧代-3-呋喃基)-萘[1,2-(:]-呋喃-1,3-二酮、 1,3,3a,4,5,9b -六氫-7 -乙基-5-(四氫-2,5-二氧代-3-呋喃基)· -14- 1354843 萘[l,2-c]-呋喃-1,3-二酮、l,3,3a,4,5,9b-六氫-8-甲基-5-(四 氫-2,5-二氧代-3-呋喃基)-萘[1,2-(:]-呋喃-1,3-二酮、 1,3,33,4,5,91)-六氫-8-乙基-5-(四氫-2,5-二氧代-3-呋喃基)-萘[1,2-c]-呋喃-1,3-二酮、1,3,3&,4,5,915-六氫-5,8-二甲基 -5-(四氫-2,5-二氧代-3-呋喃基)-萘[1,2<]-呋喃-1,3-二酮、 5-(2,5-二氧代四氫呋喃亞甲基)-3-甲基-3-環己烯-1,2-二羧 酸二酸酐、雙環[2.2.2]-辛-7-烯-2,3,5,6-四羧酸二酸酐、3-氧雜雙環[3.2.1]辛烷-2,4-二酮-6 -螺-3’ -(四氫呋喃 -2’ ,5’ -二酮)、5-(2,5-二氧代四氫-3-呋喃基)-3-甲基-3-環 己烯-1,2-二羧酸酐、3,5,6-三羧基-2-羧基降冰片烷- 2:3 ,5:6-二酐、4,9-二氧雜三環[5.3.1.02’6]十一烷-3,5,8,10-四酮、下 述式(II)和(III)表示的化合物,Among the above specific compounds, when r9 to r12 are each a hydrogen atom, a specific polyaminic acid polymer can be obtained by reacting it with an acid dianhydride. In the synthesis of the specific polyaminic acid polymer, as the acid dianhydride, for example, 1,2,3,4-cyclobutanetetracarboxylic acid dianhydride and 1,3-dimethyl-1 are preferable. 2,3,4-cyclobutanetetracarboxylic acid dianhydride, 2,3,5-tricarboxycyclopentyl acetic acid dianhydride, -12- 1354843 1,3,3a,4,5,9b-hexahydro-5 -(tetrahydro-2,5-dioxo-3-furanyl)-naphthalene[1,2-c]furan-1,3-dione, cis-3,7-dibutylcyclooctane-1 , 5-diene-1,2,5,6-tetracarboxylic dianhydride, 3,5,6-tricarbonyl-2-carboxynorbornane-2:3,5:6-dianhydride, 1,3 ,33,4,5,91)-hexahydro-8-methyl-5-(tetrahydro-2,5-dioxo-3-furanyl)-naphthalene[l,2-c]furan-1, 3-diketo' 3-oxabicyclo[3.2.1]octane-2,4-dione-6-spiro-3'-(tetrahydrofuran-2',5'-dione), 5-(2, 5-dioxotetrahydro-3-furanyl-3-methyl-3-cyclohexene-1,2-dicarboxylic anhydride, 3,5,6-tricarboxy-2-carboxynorbornane-2 : 3,5:6-dianhydride, 4,9-dioxatricyclo[5.3.1.0''6]undecane-3,5,8,10-tetraketone, pyromellitic dianhydride, and the like. These acid dianhydrides may be used alone or in combination of two or more. Further, in this case, in addition to the above specific compound having a diamine structure, other diamine compounds may be used. Preferred examples of the other diamine compound include p-phenylenediamine, 4,4'-diaminodiphenylmethane, 4,4'-diaminodiphenyl sulfide, and 2,2'-dimethylene. 4--4'-diaminobiphenyl, 1,5-diaminonaphthalene, 2,7-diaminopurine, 9,9-dimethyl-2,7-diaminopurine, 4, 4'-diaminodiphenyl ether, 2,2-bis[4-(4-aminophenoxy)phenyl]propane, 9,9-bis(4-aminophenyl)anthracene, 2, 2-bis[4-(4-aminophenoxy)phenyl]hexafluoropropane, 2,2-bis(4-aminophenyl)hexafluorodecane, 4,4'-(p-phenylene) Isopropylidene)diphenylamine, 4,4'-(m-phenylene isopropylidene)diphenylamine, 1,4-cyclohexanediamine, 4,4'-extension methyldi(cyclohexyl) Amine), 1,4-bis(4-aminophenoxy)benzene, 4,4'-bis(4-aminophenoxy)biphenyl, 2,6-diaminopyridine, 3,4- Diaminopyridine '2,4-diaminopyrimidine, 3,6-diaminoacridine, 3,6-diaminocarbazole, N-methyl-3,6-diaminocarbazole, N -ethyl-3,6-diaminocarbazole, -13- 1354843 N-phenyl-3,6-diaminocarbazole, N,N, bis(4.aminophenyl)·benzidine , Ν,Ν'-bis(4-aminophenyl) ) Ν Ν, Ν, - dimethyl-benzidine, and the like. These other -amine compounds may be used alone or in combination of two or more. [Polyuric acid] <tetracarboxylic dianhydride> In the present invention, the tetracarboxylic dianhydride used in the synthesis of the polyamic acid other than the specific polyaminic acid polymer is preferably Alicyclic tetracarboxylic acid dianhydride. Examples of the alicyclic tetracarboxylic acid dianhydride include 1,2,3,4-cyclobutanetetracarboxylic acid dianhydride and 1,2·dimethyl-1,2,3,4-cyclobutane. Alkanetetracarboxylic acid dianhydride, 1,3-dimethyl-1,2,3,4-cyclobutanetetracarboxylic acid dianhydride, 1,3-dichloro-1,2,3,4-cyclobutane Tetracarboxylic acid dianhydride, 1,2,3,4-tetramethyl-1,2,3,4-cyclobutane tetracarboxylic acid dianhydride, 1,2,3,4-cyclopentane tetracarboxylic acid Anhydride, 1,2,4,5·cyclohexanetetracarboxylic dianhydride, 3,3',4,4'-dicyclohexyltetracarboxylic dianhydride 'cis-3,7-dibutylcyclooctane -1,5-diene-1,2,5,6-tetracarboxylic acid dianhydride, 2,3,5-tricarboxycyclopentyl acetic acid dianhydride, 3,5,6-tricarbonyl-2-carboxyl group Borneol-2:3,5:6-dianhydride, 2,3,4,5-tetrahydrofuran tetracarboxylic acid diacid liver, l,3,3a,4,5,9b-hexahydro-5- (four gas -2,5-dioxo-3-furanyl)naphthalene [l,2-c]-furan-1,3-dione, 1,3,33,4,5,91)-hexahydro-5 -methyl-5-(tetrahydro-2,5-dioxo-3-furanyl)-naphthalene [l,2-c]-furan-1,3-dione, 1,3,3&,4 ,5,91)-hexahydro-5-ethyl-5-(tetrahydro-2,5-dioxo-3-furanyl)-indole [l,2-c]-furan-1,3 -di Ketone, l, 3, 3a, 4, 5, 9b - Hydrogen-7-methyl-5-(tetraki-2,5-dioxo-3-furanyl)-naphthalene [1,2-(:]-furan-1,3-dione, 1,3, 3a,4,5,9b-hexahydro-7-ethyl-5-(tetrahydro-2,5-dioxo-3-furanyl)·14- 1354843 naphthalene [l,2-c]-furan -1,3-diketone, 1,3,3a,4,5,9b-hexahydro-8-methyl-5-(tetrahydro-2,5-dioxo-3-furanyl)-naphthalene [ 1,2-(:]-furan-1,3-dione, 1,3,33,4,5,91)-hexahydro-8-ethyl-5-(tetrahydro-2,5-dioxo 3--3-furyl)-naphthalene [1,2-c]-furan-1,3-dione, 1,3,3&,4,5,915-hexahydro-5,8-dimethyl-5- (tetrahydro-2,5-dioxo-3-furanyl)-naphthalene [1,2<]-furan-1,3-dione, 5-(2,5-dioxotetrahydrofuran methylene) 3-methyl-3-cyclohexene-1,2-dicarboxylic acid dianhydride, bicyclo[2.2.2]-oct-7-ene-2,3,5,6-tetracarboxylic dianhydride, 3 -oxabicyclo[3.2.1]octane-2,4-dione-6-spiro-3'-(tetrahydrofuran-2',5'-dione), 5-(2,5-dioxotetra Hydrogen-3-furanyl)-3-methyl-3-cyclohexene-1,2-dicarboxylic anhydride, 3,5,6-tricarboxy-2-carboxynorbornane - 2:3, 5:6 - dianhydride, 4,9-dioxatricyclo[5.3.1.0''6]undecane-3,5,8,10-tetraone, formula (II) below (III) a compound represented by

(式中,R1和R3表示具有芳香環的2價有機基團,R2 和R4表示氫原子或者烷基,複數存在的R2和R4各自可以 相同,也可以不同)。 -15- 1354843 另外,還可以舉出丁烷四羧酸二酸酐等脂肪族四 二酸酐; 均苯四酸二酸酐、3,3’ ,4,4’ -二苯酮四羧酸二酸 3,3’ ,4,4’ -二苯基碾四羧酸二酸酐、1,4,5,8-萘四羧酸 酐、2,3,6,7-萘四羧酸二酸酐、3,3’ ,4,4’ -二苯基醚四 二酸酐、3,3’ ,4,4’ -二甲基二苯基矽烷四羧酸二酸 3,3’ ,4,4’ -四苯基矽烷四羧酸二酸酐、1,2,3,4-呋喃四 二酸酐、4,4’ -二(3,4-二羧基苯氧基)二苯基硫醚二酸 4,4’ -二(3,4-二羧基苯氧基)二苯基楓二酸酐、4,4’ (3,4-二羧基苯氧基)二苯基丙烷二酸酐、3,3’ ,4,4’ -全 亞丙基二苯二甲酸二酸酐、3,3’ ,4,4’ -聯苯四羧酸 酐、2,2’ ,3,3’ -聯苯四羧酸二酸酐、二(苯二甲酸)苯 化物二酸酐、對-伸苯基-二(三苯基苯二甲酸)二酸酐 伸苯基-二(三苯基苯二甲酸)二酸酐、二(三苯基苯 酸)-4,4’ -二苯醚二酸酐、二(三苯基苯二甲酸)-4,4’ - 基甲烷二酸酐、乙二醇-二(脫水偏苯三酸酯)、丙二醇 水偏苯三酸酯)、1,4-丁二醇·二(脫水偏苯三酸酯)、1 二醇-二(脫水偏苯三酸酯)、1,8-辛二醇-二(脫水偏苯 酯)、2,2-二(4-羥苯基)丙烷-二(脫水偏苯三酸酯)、下述 〜(4)表示的化合物等之芳香族四羧酸二酸酐。它們可 種單獨或2種以上組合使用。 羧酸 酐、 二酸 羧酸 酐、 羧酸 酐、 氟異 二酸 膦氧 、間-二甲 二苯 二(脫 ,6 -己 三酸 式⑴ 以1 -16- 1354843(wherein R1 and R3 represent a divalent organic group having an aromatic ring, R2 and R4 represent a hydrogen atom or an alkyl group, and each of R2 and R4 present in plural may be the same or different). -15- 1354843 Further, an aliphatic tetracarboxylic anhydride such as butane tetracarboxylic acid dianhydride; pyromellitic dianhydride; 3,3',4,4'-benzophenonetetracarboxylic acid diacid 3 may be mentioned. , 3', 4, 4'-diphenyltricarboxylic acid dianhydride, 1,4,5,8-naphthalenetetracarboxylic anhydride, 2,3,6,7-naphthalenetetracarboxylic dianhydride, 3,3 ',4,4'-diphenyl ether tetracarboxylic anhydride, 3,3',4,4'-dimethyldiphenyldecane tetracarboxylic acid diacid 3,3',4,4'-tetraphenyl Decane tetracarboxylic acid dianhydride, 1,2,3,4-furan tetracarboxylic anhydride, 4,4'-bis(3,4-dicarboxyphenoxy)diphenyl sulfide diacid 4,4'-di (3,4-dicarboxyphenoxy)diphenylgonadoic anhydride, 4,4'(3,4-dicarboxyphenoxy)diphenylpropane dianhydride, 3,3',4,4' - All-propylene dicarboxylic acid dianhydride, 3,3',4,4'-biphenyltetracarboxylic anhydride, 2,2',3,3'-biphenyltetracarboxylic dianhydride, di(phthalic acid) a phenylate dianhydride, p-phenylene-bis(triphenylphthalic acid) dianhydride, phenyl-bis(triphenylphthalic acid) dianhydride, bis(triphenylbenzoic acid)-4, 4'-diphenyl ether dianhydride, di(triphenylene) Tetraphthalic acid)-4,4'-based methane dianhydride, ethylene glycol-di(hydroper trimellitate), propylene glycol water trimellitate), 1,4-butanediol·di (dehydration) Trimellitic acid ester), 1 diol-di (dehydrated trimellitate), 1,8-octanediol-di(dehydrated phenyl ester), 2,2-bis(4-hydroxyphenyl)propane - an aromatic tetracarboxylic dianhydride such as a di(dehydrated trimellitate) or a compound represented by the following ~(4). They may be used alone or in combination of two or more. Carboxylic anhydride, diacid carboxylic anhydride, carboxylic acid anhydride, fluoroisophthalate phosphine oxide, m-dimethyldiphenyl bis(de, 6-hexanetricarboxylic acid) (1) to 1 -16 - 1354843

^CH3 ^CH3^CH3 ^CH3

(3)(3)

上述四羧酸二酸酐中,從能夠使其表現良好的液晶配 向性的角度出發,較佳爲1,2,3,4-環丁烷四羧酸二酸酐、1,3-二甲基-1,2,3,4-環丁烷四羧酸二酸酐、1,2,3,4-四甲基 -17- 1354843 -1,2,3,4-環丁烷四羧酸二酸酐、12,3,4-環戊烷四羧酸二酸 酐、2,3,5-三羧基環戊基醋酸二酸酐、5_(2,5_二氧代四氫呋 喃亞甲基)-3-甲基-3_環己烯- i,2_二羧酸二酸酐、順式_37-二丁基環辛-1,5-二烯-丨,2,5,6-四羧酸二酸酐、3,5,6-三羰基 -2-羧基降冰片烷-2:3,5:6-二酸酐、1,3,3&,4,5,91)-六氫_5-(四 氫-2,5-二氧代-3-呋喃基)_萘[1,2-(:]-呋喃-1,3-二酮、 1,3,33,4,5,91>-六氫-8_甲基_5-(四氫-2,5-二氧代-3-咲喃基)-萘[l,2-c]呋喃-1,3-二酮、1,3,33,4,5,9卜六氫-5,8-二甲基 -5-(四氫-2,5-二氧代-3·呋喃基)_萘[u-c]呋喃-1,3-二酮、雙 環[2.2.2]-辛-7-烯- 2,3,5,6 -四羧酸二酸酐、3-氧雜雙環[32.1] 辛烷-2,4-二酮-6-螺 _3,-(四氫呋喃-2,,5’ ·二酮)、5·(2,5· 二氧代四氫-3 -呋喃基)-3 -甲基-3-環己烯-1,2 -二竣酸酐、 3,5,6-三羧基-2-羧基降冰片烷-2:3,5:6-二酐、4,9-二氧雜三 環[5.3.1.02.6]十一烷_3,5,8,10-四酮、上述式(Π)表示的化合 物中的下述式(5)〜(7)表示的化合物等之脂環式四羧酸二 酸酐以及上述式(III)表示的化合物中的下述式(8)表示的化 合物等脂環式四羧酸二酸酐。作爲特佳的,可以舉出 1,2,3,4-環丁烷四羧酸二酸酐、1,3-二甲基-1,2,3,4-環丁烷四 羧酸二酸酐、2,3,5-三羧基環戊基醋酸二酸酐、 l,3,3a,4,5,9b-六氫-5-(四氫-2,5-二氧代·3-呋喃基萘 [1,2-c]·呋喃-1,3-二酮、順式-3,7-二丁 基環辛-1,5-二烯 -1,2,5,6-四羧酸二酸酐、3,5,6-三羰基-2-羧基降冰片烷 -2:3,5:6-二酸酐、1,3,3&,4,5,91)-六氫-8-甲基-5-(四氫-2,5-二 -18- 1354843 氧代-3-呋喃基)-萘[l,2-c]呋喃-1,3-二酮、3-氧雜雙環[3 辛烷-2,4-二酮-6-螺-3’ -(四氫呋喃-2’ ,5’ -二酮)、5- 二氧代四氫-3-呋喃基)-3 -甲基-3-環己烯-1,2-二羧酸 3,5,6-三羧基-2-羧基降冰片烷-2:3,5:6-二酸酐、4,9-二 三環[5.3.1.02·6]十一烷-3,5,8,10-四酮、和下述式(5)表 化合物。 .2.1] (2,5- 酐' 氧雜 示的Among the above tetracarboxylic dianhydrides, 1,2,3,4-cyclobutanetetracarboxylic dianhydride and 1,3-dimethyl- are preferable from the viewpoint of being able to exhibit good liquid crystal alignment properties. 1,2,3,4-cyclobutanetetracarboxylic acid dianhydride, 1,2,3,4-tetramethyl-17- 1354843-1,2,3,4-cyclobutane tetracarboxylic acid dianhydride, 12,3,4-cyclopentanetetracarboxylic acid dianhydride, 2,3,5-tricarboxycyclopentyl acetic acid dianhydride, 5-(2,5-dioxotetrahydrofuranmethylidene)-3-methyl- 3_cyclohexene-i,2-dicarboxylic acid dianhydride, cis-37-dibutylcyclooctane-1,5-diene-fluorene, 2,5,6-tetracarboxylic dianhydride, 3, 5,6-Tricarbonyl-2-carboxynorbornane-2:3,5:6-dianhydride, 1,3,3&,4,5,91)-hexahydro-5-(tetrahydro-2, 5-dioxo-3-furanyl)-naphthalene [1,2-(:]-furan-1,3-dione, 1,3,33,4,5,91>-hexahydro-8-A 5-5-(tetrahydro-2,5-dioxo-3-indolyl)-naphthalene [l,2-c]furan-1,3-dione, 1,3,33,4,5, 9 hexahydro-5,8-dimethyl-5-(tetrahydro-2,5-dioxo-3.furanyl)-naphthalene [uc]furan-1,3-dione, bicyclo[2.2. 2]-oct-7-ene-2,3,5,6-tetracarboxylic dianhydride, 3-oxabicyclo[32.1]octane-2,4-dione-6-spiro _3,-(tetrahydrofuran-2,5'-dione), 5·(2,5·dioxotetrahydro-3-furanyl)-3-methyl-3-cyclohexene-1,2 - Diphthalic anhydride, 3,5,6-tricarboxy-2-carboxynorbornane-2:3,5:6-dianhydride, 4,9-dioxatricyclo[5.3.1.02.6]undecane _3,5,8,10-tetraketone, an alicyclic tetracarboxylic dianhydride of a compound represented by the following formulas (5) to (7) in the compound represented by the above formula (Π), and the above formula (III) An alicyclic tetracarboxylic dianhydride such as a compound represented by the following formula (8) in the compound to be represented, and particularly preferred is 1,2,3,4-cyclobutanetetracarboxylic dianhydride. 1,3-Dimethyl-1,2,3,4-cyclobutanetetracarboxylic acid dianhydride, 2,3,5-tricarboxycyclopentyl acetic acid dianhydride, l,3,3a,4,5, 9b-hexahydro-5-(tetrahydro-2,5-dioxo-3-furanylnaphthalene [1,2-c]·furan-1,3-dione, cis-3,7-dibutyl Kecyclooctane-1,5-diene-1,2,5,6-tetracarboxylic dianhydride, 3,5,6-tricarbonyl-2-carboxynorbornane-2:3,5:6-di Anhydride, 1,3,3&,4,5,91)-hexahydro-8-methyl-5-(tetrahydro-2,5-di-18- 1354843 oxo-3-furanyl)-naphthalene l,2-c]furan-1,3-dione, 3-oxa double [3 octane-2,4-dione-6-spiro-3'-(tetrahydrofuran-2',5'-dione), 5-dioxotetrahydro-3-furanyl-3-methyl 3-cyclohexene-1,2-dicarboxylic acid 3,5,6-tricarboxy-2-carboxynorbornane-2:3,5:6-dianhydride, 4,9-ditricyclo[5.3 .1.02·6] undecane-3,5,8,10-tetraketone, and a compound of the following formula (5). .2.1] (2,5-anhydride' oxo

作爲脂環式四羧酸二酸酐以外的其他四羧酸二酸 較佳的四羧酸二酸酐,可以舉例如丁烷四羧酸二酸酐 苯四酸二酸酐、3,3’ ,4,4’ -二苯酮四羧酸二酸 酐中 、均 酐、 -19- 1354843 3,3’ ,4,4’ -聯苯颯四羧酸二酸酐、2,2’ ,3,3’ -聯苯四羧酸 二酸酐、1,4,5,8-萘四羧酸二酸酐等。 這些四羧酸二酸酐中,較佳爲脂環式四羧酸二酸酐相 對於全部四羧酸二酸酐爲50莫耳%以上。 〈二胺〉 作爲特定聚醯胺酸聚合物以外的上述聚醯胺酸合成中 所用的二胺,例如,可以舉出對-苯二胺、間-苯二胺、4,4’ - 二胺基二苯基甲烷、4,4’ -二胺基二苯基乙烷、4,4’ -二胺 基二苯基硫醚、4,4’ -二胺基二苯基楓、2,2’ -二甲基 -4,4’ -二胺基聯苯、3,3’ -二甲基-4,4’ -二胺基聯苯、 4,4’ -二胺基苯甲醯苯胺、4,4’ -二胺基二苯醚、1,5-二胺 基萘、3,3-二甲基-4,4’ -二胺基聯苯、5-胺基-1-(4’ -胺基 苯基)-1,3,3-三甲基茚滿、6-胺基-1-(4’ -胺基苯基)-1,3,3-三甲基茚滿、3,4’ -二胺基二苯基醚、3,3’ -二胺基二苯 酮、3,4’ -二胺基二苯酮、4,4’ -二胺基二苯酮、2,2-二[4-(4-胺基苯氧基)苯基]丙烷、2,2-二[4-(4-胺基苯氧基)苯基]六氟 丙烷、2,2-二(4-胺基苯基)六氟丙烷、2,2-二[4-(4-胺基苯氧 基)苯基]楓、1,4-二(4-胺基苯氧基)苯、1,3-二(4-胺基苯氧 基)苯、1,3-二(3-胺基苯氧基)苯、9,9-二(4-胺基苯基)-10-氫蒽、2,7-二胺基芴、9,9-二甲基-2,7-二胺基芴、9,9-二(4-胺基苯基)芴、4,4’ -伸甲基-二(2-氯苯胺)、2,2’ ,5,5’ -四 氯-4,4’ -二胺基聯苯、2,2’ -二氯-4,4’ -二胺基-5,5’ -二 甲氧基聯苯、3,3’ -二甲氧基-4,4’ -二胺基聯苯、 -20- 1354843 1,4,4'-(對-伸苯基異亞丙基)二苯胺、4,4’ -(間-伸苯基異 亞丙基)二苯胺、2,2’ -二[4-(4-胺基-2-三氟甲基苯氧基)苯 基]六氟丙烷、4,4’ -二胺基-2,2’ -二(三氟甲基)聯苯' 4,4'-二[(4-胺基-2-三氟甲基)苯氧基]-八氟聯苯等芳香族 二胺; 1,1-間苯二甲胺、1,3-丙二胺、丁二胺、戊二胺、己二 胺、庚二胺、辛二胺、壬二胺、4,4-二胺基庚二胺、1,4-二 胺基環己烷、異佛爾酮二胺、四氫二環戊二烯二胺、六氫 -4,7-甲撐茚二伸甲基二胺、三環[6.2.1.02·7]-十一碳烯二甲 二胺、4,4’ -伸甲基二(環己胺)、1,3-二(胺基甲基)環己烷、 1.4- 二(胺基甲基)環己烷等之脂肪族和脂環式二胺; 2,3 -二胺基吡啶、2,6 -二胺基吡啶、3,4 -二胺基吡啶、 2.4- 二胺基嘧啶、5,6-二胺基-2,3-二氰基吡嗪、5,6-二胺基 -2,4-二羥基嘧啶、2,4-二胺基-6-二甲胺基-1,3,5-三嗪、1,4-二(3-胺基丙基)呱嗪、2,4-二胺基-6-異丙氧基-1,3,5-三嗪、 2,4-二胺基-6-甲氧基-1,3,5-三嗪、2,4-二胺基-6-苯基-1,3,5-三嗪、2,4-二胺基-6-甲基-s-三嗪、2,4-二胺基-1,3,5-三嗪、 4,6-二胺基-2-乙烯基-s-三嗪、2,4-二胺基-5-苯基噻唑、2,6-二胺基嘌呤、5,6-二胺基-1,3 -二甲基尿嘧啶、3,5-二胺基 -1,2,4-三唑、6,9-二胺基-2-乙氧基吖啶乳酸酯、3,8-二胺基 -6-苯基菲啶、1,4-二胺基呱嗪、3,6-二胺基吖啶、二(4-胺 基苯基)苯基胺、3,6-二胺基咔唑、N-甲基- 3,6-二胺基咔唑、 N-乙基-3,6-二胺基咔唑、N-苯基-3,6-二胺基咔唑、Ν,Ν’- -21 - 1354843 二(4-胺基苯基)-聯苯胺、Ν,Ν’ -二(4-胺基苯基)-N,N’ -二 甲基-聯苯胺等分子內具有2個1級胺基以及該1級胺基以 外的氮原子的二胺;下述式(IV)表示的二胺基有機矽氧烷 等。這些二胺可以單獨或者2種以上組合使用。 R5 I HgN-^-CH^· Si-Preferred tetracarboxylic acid dianhydrides other than the alicyclic tetracarboxylic acid dianhydride include, butane tetracarboxylic acid dianhydride pyromellitic dianhydride, 3, 3', 4, 4 '-benzophenone tetracarboxylic acid dianhydride, homo-anhydride, -19- 1354843 3,3',4,4'-biphenylfluorene tetracarboxylic acid dianhydride, 2,2',3,3'-biphenyl Tetracarboxylic acid dianhydride, 1,4,5,8-naphthalenetetracarboxylic acid dianhydride, and the like. Among these tetracarboxylic acid dianhydrides, the alicyclic tetracarboxylic acid dianhydride is preferably 50 mol% or more based on the total tetracarboxylic acid dianhydride. <Diamine> Examples of the diamine used in the synthesis of the above polyamic acid other than the specific polyaminic acid polymer include p-phenylenediamine, m-phenylenediamine, and 4,4'-diamine. Diphenylmethane, 4,4'-diaminodiphenylethane, 4,4'-diaminodiphenyl sulfide, 4,4'-diaminodiphenyl maple, 2,2 '-Dimethyl-4,4'-diaminobiphenyl, 3,3'-dimethyl-4,4'-diaminobiphenyl, 4,4'-diaminobenzimidamide, 4,4'-diaminodiphenyl ether, 1,5-diaminonaphthalene, 3,3-dimethyl-4,4'-diaminobiphenyl, 5-amino-1-(4' -aminophenyl)-1,3,3-trimethylindan, 6-amino-1-(4'-aminophenyl)-1,3,3-trimethylindan, 3, 4'-Diaminodiphenyl ether, 3,3'-diaminobenzophenone, 3,4'-diaminobenzophenone, 4,4'-diaminobenzophenone, 2,2 - bis[4-(4-aminophenoxy)phenyl]propane, 2,2-bis[4-(4-aminophenoxy)phenyl]hexafluoropropane, 2,2-di(4 -aminophenyl)hexafluoropropane, 2,2-bis[4-(4-aminophenoxy)phenyl] maple, 1,4-bis(4-aminophenoxy)benzene, 1, 3-bis(4-aminophenoxy) Benzene, 1,3-bis(3-aminophenoxy)benzene, 9,9-bis(4-aminophenyl)-10-hydroquinone, 2,7-diaminoguanidine, 9,9 -Dimethyl-2,7-diaminopurine, 9,9-bis(4-aminophenyl)anthracene, 4,4'-methyl-bis(2-chloroaniline), 2,2' ,5,5'-tetrachloro-4,4'-diaminobiphenyl, 2,2'-dichloro-4,4'-diamino-5,5'-dimethoxybiphenyl, 3 , 3'-dimethoxy-4,4'-diaminobiphenyl, -20- 1354843 1,4,4'-(p-phenylphenylisopropylene)diphenylamine, 4,4' - (m-phenylene isopropylidene)diphenylamine, 2,2'-bis[4-(4-amino-2-trifluoromethylphenoxy)phenyl]hexafluoropropane, 4,4' -diamino-2,2'-bis(trifluoromethyl)biphenyl' 4,4'-bis[(4-amino-2-trifluoromethyl)phenoxy]-octafluorobiphenyl Aromatic diamine; 1,1-m-xylylenediamine, 1,3-propanediamine, butanediamine, pentanediamine, hexamethylenediamine, heptanediamine, octanediamine, decanediamine, 4,4 -diaminoheptamethylenediamine, 1,4-diaminocyclohexane, isophoronediamine, tetrahydrodicyclopentadienyldiamine, hexahydro-4,7-methylene quinone dimethyl Diamine, tricyclo[6.2.1.02·7]-undecene dimethyl Aliphatic and alicyclic groups such as 4,4'-methyl bis(cyclohexylamine), 1,3-bis(aminomethyl)cyclohexane, 1.4-bis(aminomethyl)cyclohexane Diamine; 2,3-diaminopyridine, 2,6-diaminopyridine, 3,4-diaminopyridine, 2.4-diaminopyrimidine, 5,6-diamino-2,3- Dicyanopyrazine, 5,6-diamino-2,4-dihydroxypyrimidine, 2,4-diamino-6-dimethylamino-1,3,5-triazine, 1,4- Bis(3-aminopropyl)pyridazine, 2,4-diamino-6-isopropoxy-1,3,5-triazine, 2,4-diamino-6-methoxy- 1,3,5-triazine, 2,4-diamino-6-phenyl-1,3,5-triazine, 2,4-diamino-6-methyl-s-triazine, 2 , 4-diamino-1,3,5-triazine, 4,6-diamino-2-vinyl-s-triazine, 2,4-diamino-5-phenylthiazole, 2, 6-Diaminopurine, 5,6-diamino-1,3-dimethyluracil, 3,5-diamino-1,2,4-triazole, 6,9-diamino- 2-ethoxy acridine lactate, 3,8-diamino-6-phenylphenanthridine, 1,4-diaminopyridazine, 3,6-diaminoacridine, di(4- Aminophenyl)phenylamine, 3,6-diaminocarbazole, N-methyl-3,6-diaminocarbazole, N-ethyl-3,6-diaminoguanidine , N-phenyl-3,6-diaminocarbazole, hydrazine, Ν'- -21 - 1354843 bis(4-aminophenyl)-benzidine, anthracene, Ν'-bis(4-aminobenzene) a diamine having two first-order amine groups and a nitrogen atom other than the first-order amine group in a molecule such as N-N,N'-dimethyl-benzidine; and a diamine-based organic compound represented by the following formula (IV) Oxane and the like. These diamines may be used alone or in combination of two or more. R5 I HgN-^-CH^· Si-

(IV)(IV)

(式中,R5表示碳數爲1〜12的烴基,複數存在的R5 各自可以相同也可以不同,p爲1〜3的整數,q爲1〜;20 的整數)。 其中,較佳爲對-苯二胺、4,4’ -二胺基二苯甲烷、4,4’ - 二胺基二苯硫醚、2,2’ -二甲基-4,4,-二胺基聯苯、1,5-二 胺基萘、2,7-二胺基芴、9,9-二甲基-2,7-二胺基芴、4,4’ -二胺基二苯醚、2,2-二[4_(4-胺基苯氧基)苯基]丙烷、9,9-二(4-胺基苯基)芴、2,2-二[4-(4-胺基苯氧基)苯基]六氟丙 烷、2,2-二(4-胺基苯基)六氟丙烷、4,4’ -(對-伸苯基二異亞 丙基)二苯胺、4,4’ -(間-伸苯基二異亞丙基)二苯胺、l,4- 環己烷二胺、4,4’ -伸甲基二(環己胺)、1,3-二(胺基甲基) 環己烷、1,4-二(4-胺基苯氧基)苯、4,4’ ·二(4-胺基苯氧基) 聯苯、2,6-二胺基吡啶、3,4-二胺基吡啶、2,4-二胺基嘧啶、 3,6-二胺基吖啶、3,6·二胺基咔唑、N·甲基-3,6-二胺基咔 唑、N-乙基-3,6·二胺基咔唑、N·苯基-3,6-二胺基咔唑、 N,N’ -二(4-胺基苯基)-聯苯胺等。 -22- 1354843 &amp;使本發明液晶配向劑具有預傾角表現性能時,較佳 爲上述式(I — 1)和(I — 2)中的Q|、Q2的—部分或全部爲下述 式(Q — 1)和下述式(Q — 2)表示的至少一種基團。即,使用 具有下述式(Q— 1)或下述式(q — 2)表示的基團的二胺(以下 也稱爲‘‘特定二胺”)。它們可以1種單獨或2種以上組合 使用。(In the formula, R5 represents a hydrocarbon group having 1 to 12 carbon atoms, and R5 each may be the same or different, p is an integer of 1 to 3, and q is an integer of 1 to 20; Among them, p-phenylenediamine, 4,4'-diaminodiphenylmethane, 4,4'-diaminodiphenyl sulfide, 2,2'-dimethyl-4,4,- are preferred. Diaminobiphenyl, 1,5-diaminonaphthalene, 2,7-diaminoguanidine, 9,9-dimethyl-2,7-diaminopurine, 4,4'-diaminodi Phenyl ether, 2,2-bis[4-(4-aminophenoxy)phenyl]propane, 9,9-bis(4-aminophenyl)anthracene, 2,2-di[4-(4- Aminophenoxy)phenyl]hexafluoropropane, 2,2-bis(4-aminophenyl)hexafluoropropane, 4,4'-(p-phenylphenyldiisopropylidene)diphenylamine, 4,4'-(m-phenylene diisopropylidene)diphenylamine, 1,4-cyclohexanediamine, 4,4'-methyl bis(cyclohexylamine), 1,3-two (Aminomethyl) cyclohexane, 1,4-bis(4-aminophenoxy)benzene, 4,4'-bis(4-aminophenoxy)biphenyl, 2,6-diamine Pyridine, 3,4-diaminopyridine, 2,4-diaminopyrimidine, 3,6-diaminoacridine, 3,6-diaminocarbazole, N-methyl-3,6- Diaminocarbazole, N-ethyl-3,6-diaminocarbazole, N-phenyl-3,6-diaminocarbazole, N,N'-bis(4-aminophenyl) -benzidine and the like. -22- 1354843 &amp; When the liquid crystal alignment agent of the present invention has a pretilt performance performance, it is preferred that some or all of Q| and Q2 in the above formulas (I-1) and (I-2) are as follows: (Q-1) and at least one group represented by the following formula (Q-2). In other words, a diamine having a group represented by the following formula (Q-1) or the following formula (q-2) (hereinafter also referred to as ''specific diamine') is used. They may be used alone or in combination of two or more. Used in combination.

(式中,X 爲單鍵、-〇-、-CO-、-COO-、-OCO-、-NHCO-、 -CONH-、-S-或伸芳基,R6是碳數爲10〜20的烷基、碳數 爲4〜40的具有脂環式骨架的1價有機基團或者碳數爲6 〜20的含氟原子的1價有機基團)。(wherein X is a single bond, -〇-, -CO-, -COO-, -OCO-, -NHCO-, -CONH-, -S- or an aryl group, and R6 is a carbon number of 10 to 20 An alkyl group, a monovalent organic group having an alicyclic skeleton of 4 to 40 carbon atoms or a monovalent organic group having a fluorine atom of 6 to 20 carbon atoms).

(式中,X 爲單鍵、-0-、 -CO·、 -COO-、 -OCO-、 -NHCO-、 -C0NH-、-S-或伸芳基,R7是碳數爲4〜40的具有脂環式骨 架的2價有機基團)。 上述式(Q— 1)中,作爲R6表示的碳數爲10〜20的烷 基,可以舉例如正癸基、正十二烷基、正十五烷基、正十 六烷基、正十八烷基、正二十烷基等。另外,作爲上述式 (Q—1)的R6和上述式(Q — 2)中的R7表示的碳數爲4〜40的 具有脂環式骨架的有機基團,可以舉例如具有來源於環丁 -23- 1354843 烷、環戊烷、環己烷、環癸烷等環烷的脂環式骨架的基團; 具有膽甾醇、膽甾烷醇等甾體骨架的基團;具有降冰片烯、 金剛烷等有橋脂環式骨架的基團等。其中,特佳爲具有甾 體骨架的基團。具有上述脂環式骨架的有機基團還可以是 被鹵素原子(較佳爲氟原子)或氟代烷基(較佳爲三氟甲基) 取代的基團。 此外,作爲上述式(Q — 1)的R6表示的碳數爲6〜20的 含氟原子的基團,可以舉例如正己基、正辛基、正癸基等 碳數爲6以上的直鏈烷基;環己基、環辛基等碳數爲6以 上的脂環式烴基;苯基、聯苯基等碳數爲6以上的芳香族 烴基等有機基團的氫原子之一部分或全部被氟原子或三氟 甲基等氟代烷基取代的基團。 另外’上述式(Q — 1)和上述式(Q-2)中的X爲單鍵、 -〇- ' -CO- ' -COO- ' -OCO- &gt; -NHC0- ' -CONH- ' 或者伸 芳基,作爲伸芳基,可以舉例如伸苯基、伸甲苯基、伸聯 苯基、伸萘基等。其中,特佳爲- 0-、-COO-、-OCO -表示的 基團。作爲具有上述式(Q - 1)表示的基團的二胺的具體例 子’較佳的可以舉出十二烷氧基-2,4·二胺基苯、十五烷氧 基-2,4-二胺基苯、十六烷氧基-2,4-二胺基苯、十八烷氧基 •2,4-二胺基苯、下述式(9)〜(13)表示的化合物。 •24- 1354843(wherein X is a single bond, -0-, -CO·, -COO-, -OCO-, -NHCO-, -C0NH-, -S- or an aryl group, and R7 is a carbon number of 4 to 40. a divalent organic group having an alicyclic skeleton). In the above formula (Q-1), the alkyl group having 10 to 20 carbon atoms represented by R6 may, for example, be n-decyl, n-dodecyl, n-pentadecyl, n-hexadecyl or n. Octaalkyl, n-icosyl, and the like. In addition, as the organic group having an alicyclic skeleton having 4 to 40 carbon atoms represented by R6 of the above formula (Q-1) and R7 in the above formula (Q-2), for example, -23- 1354843 a group of an alicyclic skeleton of a cycloalkane such as an alkane, a cyclopentane, a cyclohexane or a cyclodecane; a group having a steroid skeleton such as cholesterol or cholestyl alcohol; having a norbornene; A group having a bridged alicyclic skeleton such as adamantane. Among them, a group having a steroid skeleton is particularly preferred. The organic group having the above alicyclic skeleton may also be a group substituted by a halogen atom (preferably a fluorine atom) or a fluoroalkyl group (preferably a trifluoromethyl group). Further, the fluorine atom-containing group having 6 to 20 carbon atoms represented by R6 in the above formula (Q-1) may, for example, be a straight chain having 6 or more carbon atoms such as n-hexyl group, n-octyl group or n-decyl group. An alkyl group; an alicyclic hydrocarbon group having 6 or more carbon atoms such as a cyclohexyl group or a cyclooctyl group; and a part or all of a hydrogen atom of an organic group such as an aromatic hydrocarbon group having 6 or more carbon atoms such as a phenyl group or a biphenyl group; a group substituted with a fluoroalkyl group such as an atom or a trifluoromethyl group. Further, 'X in the above formula (Q-1) and the above formula (Q-2) is a single bond, -〇- '-CO- ' -COO- ' -OCO- &gt; -NHC0- ' -CONH- ' or The aryl group, as the aryl group, may, for example, be a phenyl group, a tolyl group, a phenyl group, a naphthyl group or the like. Among them, a group represented by -0-, -COO-, -OCO- is particularly preferred. Specific examples of the diamine having a group represented by the above formula (Q-1) are preferably dodecyloxy-2,4·diaminobenzene and pentadecyloxy-2,4. -diaminobenzene, hexadecyloxy-2,4-diaminobenzene, octadecyloxy-2,4-diaminobenzene, a compound represented by the following formulas (9) to (13). •24- 1354843

(13) 另外,作爲具有上述式(Q - 2)表示的基團的二胺的具 體例子,較佳的可以舉出下述式(14)〜(16)表示的二胺。(13) Further, as a specific example of the diamine having a group represented by the above formula (Q-2), preferred are diamines represented by the following formulas (14) to (16).

其中,作爲特佳的,可以舉出上述式(9)、(11)、(13)、 (14)各自表示的化合物。 -25- 1354843 特定二胺之相對於全部二胺量的使用比率,隨著所要 使其表現的預傾角的大小而不同,對於TN型、STN型液晶 顯示元件的情況’較佳爲0〜5莫耳%,對於垂直配向型液 晶顯示元件的情況,較佳爲5〜1 〇 〇莫耳%。 &lt;聚醯胺酸的合成&gt; 供給聚醯胺酸(包括特定聚醯胺酸聚合物)合成反應的 四羧酸二酸酐與二胺的使用比率,較佳爲相對於1當量二 胺的胺基’使四羧酸二酸酐的酸酐基爲0.2〜2當量的比 率,更佳爲使其爲0.3〜1.2當量的比率。 聚醯胺酸的合成反應,在有機溶劑中,較佳爲於_2(TC 〜150 °C、更佳爲於〇〜100°C的溫度條件下進行。 這裏’作爲有機溶劑’只要能夠溶解合成的聚醯胺酸, 則對其沒有特別的限制,可以例示例如卜甲基-2 -吡咯烷 酮、N,N-二甲基乙醯胺、N,N-二甲基甲醯胺、3-丁氧基- Ν,Ν-二甲基丙醯胺、3-甲氧基Ν,Ν-二甲基丙醯胺、3-己氧基·Ν,Ν-二甲基丙醯胺等醯胺類溶劑、二甲基亞颯、7_丁內酯、四 甲基脲、六甲基磷醯三胺等非質子系極性溶劑;間甲基酚、 二甲苯酚、苯酚、鹵代苯酚等酚類溶劑。此外,有機溶劑 的用量(α )通常較佳爲使四羧酸二酸酐和二胺化合物的總 量(沒)相對於反應溶液的總量(α +卢)爲0. 1〜30重量%的 量。 另外’在不使生成的聚醯胺酸析出的範圍內,上述有 機溶劑中還可以倂用聚醯胺酸的不良溶劑(poor sol vent)醇 -26- 1354843 類、酮類、酯類、酸類、鹵代烴類、烴類等。作爲這種不 良溶劑的具體例子,可以舉例如甲醇、乙醇、異丙醇、環 己醇、4-羥基-4-甲基·2·戊酮、乙二醇、丙二醇、丨,4· 丁二 醇、三甘醇、乙二醇單甲醚、乳酸乙酯、乳酸丁酯、丙酮、 甲基乙基酮、甲基異丁基酮、環己酮、醋酸甲酯、醋酸乙 酯、醋酸丁酯、甲氧基丙酸甲酯、乙氧基丙酸乙酯、草酸 二乙酯、丙二酸二乙酯、二乙基醚、乙二醇甲醚、乙二醇 乙醚、乙二醇正丙醚、乙二醇異丙醚、乙二醇正丁醚、乙 二醇二甲基醚 '乙二醇乙醚乙酸酯、二甘醇二甲醚、二甘 醇二乙醚、二甘醇單甲醚、二甘醇單乙醚、二甘醇單甲醚 乙酸酯、二甘醇單乙醚乙酸酯、四氫呋喃、二氯甲烷、1,2_ 二氯乙烷、1,4-二氯丁烷、三氯乙烷、氯苯、鄰二氯苯、己 焼、庚垸、辛院、苯、甲苯、二甲苯、丙酸異戊醋、異丁 酸異戊酯、二異戊基醚等。 如上所述,得到溶解了聚醯胺酸的反應溶液。然後, 將該反應溶液投入到大量的不良溶劑中,得到析出物,通 過減壓下乾燥該析出物或用蒸發器將反應溶液減壓餾出能 夠獲得聚醯胺酸。並且,通過進行一次或者數次使該聚醯 胺酸再次溶解於有機溶劑中,然後用不良溶劑使其析出之 製程,可以精製聚醯胺酸。 &lt;脫水閉環反應&gt; 構成本發明液晶配向劑的聚醯亞胺可以通過將上述聚 醯胺酸的一部分或全部脫水閉環而合成。本發明中所用的 -27- 1354843 聚醯亞胺全部重複單元中具有醯亞胺環的重複單元的比率 (以下,也稱爲“醯亞胺化率”)爲40莫耳%以上,較佳爲 50莫耳%以上。通過使用醯亞胺化率爲40莫耳%以上的聚 合物,可以獲得能夠形成殘像消除時間短的液晶配向 液晶配向劑。醯亞胺化率可根據下述方法求出。 [醯亞胺化聚合物的醯亞胺化率測定方法] 將醯亞胺化聚合物在室溫下減壓乾燥後,溶解在気代 二甲基亞颯中,以四甲基矽烷爲基準物質,在室溫下進行 W-NMR測定。以下述(ii)表示的公式求得》 醯亞胺化率(%) = (Ι—Α'/Α^α )χ100----(ϋ) Α1:來源於ΝΗ基的質子的峰値面積(l〇ppm) A2:來源於其他的質子的峰値面積 α :聚合物的前驅物(聚醯胺酸)中,相對於1個NH基 質子的其他質子的個數比例 聚醯胺酸的脫水閉環係爲,(i)通過加熱聚醯胺酸的方 法,或者(ii)通過將聚醯胺酸溶解於有機溶劑中,向該溶液 中加入脫水劑和脫水閉環催化劑並根據需要加熱的方法而 進行。 上述(i)的加熱聚醯胺酸的方法中的反應溫度,較佳爲 50〜20 0°C,更佳爲60〜17(TC。當反應溫度不足50°C時, 則脫水閉環反應不能進行完全,如果反應溫度超過200°C, 則會出現所得醯亞胺化聚合物的分子量下降的情況。 另一方面,在上述(ii)的在聚醯胺酸溶液中添加脫水劑 -28- 1354843 和脫水閉環催化劑的方法中,作爲脫水劑,可以使 醋酸酐、丙酸酐、三氟乙酸酐等酸酐。脫水劑的用 據所需醯亞胺化率而定,較佳爲相對於1莫耳聚醯 重複單元,爲0.01〜20莫耳》另外,作爲脫水閉環催 可以使用例如吡啶、三甲吡啶、二甲吡啶、三乙胺 胺。但是,並不局限於這些。脫水閉環催化劑的用 對於1莫耳所用之脫水劑,較佳爲0.0 1〜1 〇莫耳。 水劑、脫水閉環催化劑的用量越多,則可使醯亞胺 高。此外,作爲脫水閉環反應中使用的有機溶劑, 出作爲聚醯胺酸合成中所用溶劑而例示的有機溶 且,脫水閉環反應的反應溫度較佳爲0〜180 °C,更 〜150 °C。此外,通過對如此得到的反應溶液進行與 酸之精製方法同樣的操作,可以精製所得之特定聚 &lt;末端修飾型之聚合物&gt; 本發明中所用的聚醯胺酸和聚醯亞胺還可以是 分子量調節的末端修飾型聚合物。通過使用該末端 聚合物,可以在不損害本發明效果的前提下改善液 劑的塗敷特性等。這種末端修飾型之聚合物可以通 醯胺酸的合成時,向反應體系中加入一元酸酐 '單 物、單異氰酸酯化合物等而合成。其中’作爲一元 可以舉例如馬來酸酐、苯二甲酸酐、衣康酸酐、正 珀酸酐、正十二烷基琥珀酸酐、正十四烷基號拍酸 十六烷基琥珀酸酐等。此外,作爲單胺化合物’可 用例如 量,根 胺酸的 丨化劑, 等3級 量,相 上述脫 化率越 可以舉 劑。並 佳爲10 聚醯胺 合物。 進行了 修飾型 晶配向 過在聚 胺化合 酸酐, 癸基琥 酐、正 以舉例 -29- 1354843 如苯胺、環己胺、正丁胺、正戊胺、正己胺、正庚胺 辛胺、正壬胺、正癸胺、正十一烷胺、正十二烷胺、 三烷胺、正十四烷胺、正十五烷胺、正十六烷胺、正 烷胺、正十八烷胺、正二十烷胺等。此外,作爲單異 酯化合物,可以舉例如異氰酸苯酯、異氰酸萘基酯等 [溶液黏度] 使用於本發明的配向劑的聚合物,在10 %的溶液 況下,較佳爲具有20〜800mPa‘s黏度,更佳爲具有 500mPa‘s 黏度。 另外,使用特定的溶劑,對於稀釋到特定的固體 濃度的溶液,用E型旋轉黏度計在2 5 °C下測定聚合物 液黏度(mPa‘s)。 [液晶配向劑] 本發明的液晶配向劑通常是將特定化合物、或特 醯胺酸聚合物較佳爲上述聚合物、以及任意添加的其 分溶解含於有機溶劑中而構成。 本發明的液晶配向劑在不損害目的之物性的範圍 從提高對基板表面接著性的角度考慮,還可以含有環 化合物、含官能性矽烷的化合物。作爲這種環氧基化会 可以舉例如乙二醇二縮水甘油醚 '聚乙二醇二縮水 醚、丙二醇二縮水甘油醚、三丙二醇二縮水甘油醚、 二醇二縮水甘油醚、新戊二醇二縮水甘油醚、1&gt;6-己二 縮水甘油醚、甘油二縮水甘油醚、2,2-二溴新戊二醇二 、正 正十 十七 氰酸 的情 3 0〜 成分 的溶 定聚 他成 內, 氧基 •物, 甘油 聚丙 醇二 縮水 -30- 1354843 甘油醚、1,3,5,6 -四縮水甘油基-2,4 -己二醇、Ν,Ν,Ν’ 四縮水甘油基-間·苯二甲胺、1,3 -二(Ν,Ν -二縮水甘 基甲基)環己烷、Ν,Ν,Ν’ ,Ν’ -四縮水甘油基·4,4’ - 二苯基甲烷、3-(Ν-烯丙基-Ν-縮水甘油基)胺基丙基 基矽烷、3-(Ν,Ν-二縮水甘油基)胺基丙基三甲氧基 Ν,Ν-二縮水甘油基-苄基胺基、Ν,Ν-二縮水甘油基-胺 環己院等。並且,作爲含環氧基化合物,較佳的可 如乙二醇二縮水甘油醚、聚乙二醇二縮水甘油醚、 二縮水甘油醚、三丙二醇二縮水甘油醚、聚丙二醇 甘油醚、新戊二醇二縮水甘油醚、1,6 -己二醇二縮 醚、甘油二縮水甘油醚、2,2-二溴新戊二醇二縮水甘 1,3,5,6-四縮水甘油基-2,4-己二醇、^^,化-四 油基-間-苯二甲胺、1,3-二(Ν,Ν-二縮水甘油基胺基I 己烷、Ν,Ν,Ν’ ,Ν’ ·四縮水甘油基-4,4’ -二胺基二 烷、Ν,Ν-二縮水甘油基-苄基胺、Ν,Ν-二縮水甘油基· 基環己烷等。這些含環氧基化合物的配合比例,相f 重量份聚合物,較佳爲40重量份以下,更佳爲0.1 量份。 作爲這種含官能性矽烷的化合物,可以舉例如 丙基三甲氧基矽烷、3-胺基丙基三乙氧基矽烷、2. 基三甲氧基矽烷、2-胺基丙基三乙氧基矽烷、N-(2 基)-3-胺基丙基三甲氧基矽烷、N-(2-胺基乙基)-3-胺 甲基二甲氧基矽烷、3-脲基丙基三甲氧基矽烷、3 ,Ν,-油基胺 二胺基 三甲氧 矽烷、 基甲基 以舉例 丙二醇 二縮水 水甘油 •油醚、 縮水甘 甲基)環 苯基甲 -胺基甲 if 於 100 〜30重 3·胺基 -胺基丙 -胺基乙 基丙基 -脲基丙 -31 - 1354843 基三乙氧基矽烷' N-乙氧羰基-3·胺基丙基三甲氧基矽烷、 Ν -乙氧羰基-3-胺基丙基三乙氧基矽烷、N-三乙氧基矽烷基 丙基三伸乙基三胺、Ν -三甲氧基矽烷基丙基三伸乙基三 胺、10-二甲氧基矽烷基_1,4,7-三氮雜癸烷、ι〇·三乙氧基矽 垸基-1,4,7-三氮雜癸烷、9-三甲氧基矽烷基-3,6-二氮雜壬 基乙酸酯、9-三乙氧基矽烷基-3,6·二氮雜壬基乙酸酯、Ν-节基-3-胺基丙基三甲氧基矽烷、Ν·苄基·3_胺基丙基三乙氧 基矽烷、Ν -苯基-3-胺基丙基三甲氧基砂烷、Ν_苯基_3_胺基 丙基三乙氧基矽烷、Ν-二(氧乙烯基)-3-胺基丙基三甲氧基 砂烷、N-二(氧乙烯基)-3-胺基丙基三乙氧基矽烷等。作爲 含官能性矽烷化合物的配合比例,相對於1〇〇重量份聚合 物,較佳爲4重量份以下。 作爲構成本發明液晶配向劑的有機溶劑,例如,可以 舉出1_甲基-2-吡略烷酮、r·丁內酯、r-丁內醯胺、ν,ν-二甲基甲醯胺、Ν,Ν-二甲基乙醯胺、4-羥基-4-甲基·2-戊 酮、乙二醇單甲醚、乳酸丁酯、乙酸丁酯、甲氧基丙酸甲 酯、乙氧基丙酸乙酯、乙二醇甲醚、乙二醇乙醚、乙二醇 正丙醚、乙二醇異丙醚、乙二醇正丁醚(丁基溶纖劑)、乙 二醇二甲基醚、乙二醇乙醚乙酸酯、二甘醇二甲醚、二甘 醇二乙醚、二甘醇單甲醚、二甘醇單乙醚、二甘醇單甲醚 乙酸酯、二甘醇單乙醚乙酸酯、3-丁氧基-Ν,Ν·二甲基丙醯 胺、3-甲氧基- Ν,Ν-二甲基丙醯胺、3-己基氧基-Ν,Ν-二甲基 丙醯胺 '丙酸異戊酯、異丁酸異戊酯、二異戊基醚等。其 -32-Among them, particularly preferred are compounds represented by the above formulas (9), (11), (13), and (14). -25- 1354843 The ratio of use of the specific diamine to the amount of all diamines varies depending on the magnitude of the pretilt angle to be expressed. For the case of TN type and STN type liquid crystal display elements, it is preferably 0 to 5 The molar % is preferably 5 to 1% by mole for the case of the vertical alignment type liquid crystal display element. &lt;Synthesis of Polyglycine&gt; The ratio of use of the tetracarboxylic dianhydride to the diamine for the synthesis reaction of poly-proline (including a specific poly-proline polymer) is preferably relative to 1 equivalent of the diamine. The amine group 'the acid anhydride group of the tetracarboxylic acid dianhydride is a ratio of 0.2 to 2 equivalents, more preferably 0.3 to 1.2 equivalents. The synthesis reaction of polylysine is preferably carried out in an organic solvent at a temperature of _2 (TC ~ 150 ° C, more preferably 〇 100 ° C. Here, 'as an organic solvent' as long as it can be dissolved The synthetic polyaminic acid is not particularly limited, and examples thereof include, for example, methyl-2-pyrrolidone, N,N-dimethylacetamide, N,N-dimethylformamide, 3-butoxy Amidoxime solvent such as hydrazine, hydrazine-dimethylpropanamide, 3-methoxy hydrazine, hydrazine-dimethylpropionamide, 3-hexyloxy hydrazine, hydrazine-dimethylpropionamide , aprotic polar solvents such as dimethyl hydrazine, 7-butyrolactone, tetramethyl urea, hexamethylphosphonium triamine; phenolic solvents such as m-methylphenol, xylenol, phenol, halogenated phenol, etc. 1〜30重量百分比。 The total amount of the total amount of the tetracarboxylic acid dianhydride and the diamine compound (n) relative to the total amount of the reaction solution (α + Lu) is 0. 1~30% by weight In addition, in the range in which the produced polyamine acid is not precipitated, the organic solvent may also be a poor solvent of poly lysine, -26- 1354843, Examples, esters, acids, halogenated hydrocarbons, hydrocarbons, etc. Specific examples of such a poor solvent include methanol, ethanol, isopropanol, cyclohexanol, and 4-hydroxy-4-methyl-2. · Pentanone, ethylene glycol, propylene glycol, hydrazine, 4 · butanediol, triethylene glycol, ethylene glycol monomethyl ether, ethyl lactate, butyl lactate, acetone, methyl ethyl ketone, methyl isobutyl Ketone, cyclohexanone, methyl acetate, ethyl acetate, butyl acetate, methyl methoxypropionate, ethyl ethoxy propionate, diethyl oxalate, diethyl malonate, diethyl ether , ethylene glycol methyl ether, ethylene glycol ether, ethylene glycol n-propyl ether, ethylene glycol isopropyl ether, ethylene glycol n-butyl ether, ethylene glycol dimethyl ether 'ethylene glycol ether acetate, diethylene glycol Dimethyl ether, diethylene glycol diethyl ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monomethyl ether acetate, diethylene glycol monoethyl ether acetate, tetrahydrofuran, dichloromethane, 1, 2_ dichloroethane, 1,4-dichlorobutane, trichloroethane, chlorobenzene, o-dichlorobenzene, hexanthene, gypsum, xinyuan, benzene, toluene, xylene, isonic acid Isobutyric acid Ester, diisoamyl ether, etc. As described above, a reaction solution in which polyamic acid is dissolved is obtained. Then, the reaction solution is poured into a large amount of poor solvent to obtain a precipitate, and the precipitate is dried under reduced pressure. Or the reaction solution can be distilled off under reduced pressure with an evaporator to obtain a poly-proline acid, and the process of dissolving the poly-proline in an organic solvent once or several times, and then precipitating it with a poor solvent can be used. Refined polyaminic acid. <Dehydration ring closure reaction> The polyimine constituting the liquid crystal alignment agent of the present invention can be synthesized by dehydration ring closure of a part or all of the above polyamic acid. -27- 1354843 used in the present invention. The ratio of the repeating unit having a quinone ring in all repeating units of polyimine (hereinafter also referred to as "deuterated imidization ratio") is 40 mol% or more, preferably 50 mol% or more. By using a polymer having a ruthenium iodide ratio of 40 mol% or more, a liquid crystal alignment liquid crystal alignment agent capable of forming a afterimage erasing time can be obtained. The ruthenium amination rate can be determined by the following method. [Method for Measuring the Amidation Rate of the Iridium Amineated Polymer] The ruthenium iodide polymer is dried under reduced pressure at room temperature, and then dissolved in deuterated dimethyl hydrazine, based on tetramethyl decane. The substance was subjected to W-NMR measurement at room temperature. It is obtained by the formula expressed by the following formula (ii): 醯 imidization ratio (%) = (Ι—Α'/Α^α ) χ100----(ϋ) Α1: peak area of protons derived from sulfhydryl groups (l〇ppm) A2: peak area α derived from other protons: the ratio of the number of other protons in the precursor of the polymer (polyproline) to the proton of one NH matrix The dehydration ring closure is (i) a method of heating poly-proline, or (ii) a method of dissolving a polyhydrazide in an organic solvent, adding a dehydrating agent and a dehydration ring-closing catalyst to the solution, and heating as needed. And proceed. The reaction temperature in the method for heating poly-proline in the above (i) is preferably 50 to 20 ° C, more preferably 60 to 17 (TC. When the reaction temperature is less than 50 ° C, the dehydration ring-closure reaction cannot be Completely, if the reaction temperature exceeds 200 ° C, the molecular weight of the obtained ruthenium-imided polymer may decrease. On the other hand, the dehydrating agent -28- is added to the poly-proline solution in the above (ii). In the method of 1354843 and the dehydration ring-closing catalyst, an acid anhydride such as acetic anhydride, propionic anhydride or trifluoroacetic anhydride may be used as the dehydrating agent, and the dehydrating agent may be used depending on the desired imidization ratio, preferably relative to 1 mol. The agglutination repeating unit is 0.01 to 20 moles. Further, as the dehydration ring closure, for example, pyridine, trimethylpyridine, dimethylpyridine or triethylamine can be used. However, it is not limited thereto. 1 The dehydrating agent used in the molar is preferably 0.01 to 1 Torr. The more the amount of the aqueous solvent and the dehydration ring-closing catalyst, the higher the quinone imine. Moreover, as the organic solvent used in the dehydration ring-closing reaction, Polyglycine The organic solvent is exemplified as the solvent used in the solvent, and the reaction temperature of the dehydration ring-closure reaction is preferably from 0 to 180 ° C, more preferably from 150 to C. Further, by subjecting the reaction solution thus obtained to the same operation as the acid purification method, The specific poly <end-modified type polymer which can be obtained by refining> The poly-proline and polyimine used in the present invention may also be a molecularly-modified terminal-modified polymer. By using the terminal polymer, The coating property and the like of the liquid agent can be improved without impairing the effects of the present invention. The terminal-modified polymer can be added to the reaction system by adding a monobasic acid anhydride, a monoisocyanate compound, etc., to the reaction system. And synthesis. Among them, 'as a unitary one, for example, maleic anhydride, phthalic anhydride, itaconic anhydride, n-benzoic anhydride, n-dodecyl succinic anhydride, n-tetradecyl citrate cetyl succinic anhydride, etc. Further, as the monoamine compound, for example, an amount of a deuterated acid, such as a deuterated acid, may be used in a three-stage amount, and the above-mentioned deuteration ratio is more likely to be mentioned. Preferably, it is a 10-mer amide compound. Modified crystals were passed over the polyamine anhydride, decyl succinic anhydride, by way of example -29- 1354843 such as aniline, cyclohexylamine, n-butylamine, n-pentylamine, n-hexylamine, n-heptylamine, positive Indoleamine, n-decylamine, n-undecylamine, n-dodecylamine, trialkylamine, n-tetradecylamine, n-pentadecylamine, n-hexadecylamine, n-alkylamine, n-octadecylamine Further, as the monoisoester ester compound, for example, phenyl isocyanate or naphthyl isocyanate [solution viscosity], the polymer used in the alignment agent of the present invention, at 10% In the case of a solution, it preferably has a viscosity of 20 to 800 mPa's, more preferably a viscosity of 500 mPa's. In addition, using a specific solvent, for a solution diluted to a specific solid concentration, an E-type rotational viscometer is used in 2 The viscosity of the polymer solution (mPa's) was measured at 5 °C. [Liquid crystal alignment agent] The liquid crystal alignment agent of the present invention is usually composed of a specific compound or a polyglycolic acid polymer, preferably the above polymer, and optionally added components, which are dissolved in an organic solvent. The liquid crystal alignment agent of the present invention may further contain a cyclic compound or a functional decane-containing compound from the viewpoint of improving the adhesion to the surface of the substrate without impairing the physical properties of the object. Examples of such epoxidation include ethylene glycol diglycidyl ether 'polyethylene glycol di-distillate, propylene glycol diglycidyl ether, tripropylene glycol diglycidyl ether, diol diglycidyl ether, and neopentyl Alcohol diglycidyl ether, 1&gt;6-hexane diglycidyl ether, glycerol diglycidyl ether, 2,2-dibromo neopentyl glycol II, ortho-cyanate cyanate 3 0~ composition melting Poly-integrated, oxy-property, glycerol-polypropyl alcohol dihydrate -30- 1354843 glyceryl ether, 1,3,5,6-tetraglycidyl-2,4-hexanediol, hydrazine, hydrazine, Ν' four Glycidyl-m-xylylenediamine, 1,3-bis(indole, fluorene-di-glycidylmethyl)cyclohexane, hydrazine, hydrazine, Ν', Ν'-tetraglycidyl group 4,4 '-Diphenylmethane, 3-(Ν-allyl-indole-glycidyl)aminopropyl decane, 3-(anthracene, Ν-diglycidyl)aminopropyltrimethoxyanthracene, Ν-diglycidyl-benzylamine, hydrazine, hydrazine-diglycidyl-amine cyclohexanthes and the like. Further, as the epoxy group-containing compound, preferred are, for example, ethylene glycol diglycidyl ether, polyethylene glycol diglycidyl ether, diglycidyl ether, tripropylene glycol diglycidyl ether, polypropylene glycol glyceryl ether, and neopentyl Glycol diglycidyl ether, 1,6-hexanediol dicondensate, glycerol diglycidyl ether, 2,2-dibromoneopentyl glycol diglycid 1,3,5,6-tetraglycidyl- 2,4-hexanediol, ^^,-tetrakilyl-m-xylylenediamine, 1,3-bis(indole, fluorene-diglycidylamino) hexane, hydrazine, hydrazine, hydrazine , Ν' · tetraglycidyl-4,4'-diaminodiazane, hydrazine, hydrazine-diglycidyl-benzylamine, hydrazine, hydrazine-diglycidyl ylcyclohexane, etc. These include The blending ratio of the epoxy group compound is preferably 40 parts by weight or less, more preferably 0.1 parts by weight, based on the part by weight of the polymer. Examples of the functional decane-containing compound include propyltrimethoxydecane. 3-aminopropyltriethoxydecane, 2.-trimethoxydecane, 2-aminopropyltriethoxydecane, N-(2-yl)-3-aminopropyltrimethoxydecane, N-(2-Aminoethyl)-3-aminomethyl Methoxydecane, 3-ureidopropyltrimethoxydecane, 3, anthracene, -oleylamine diaminotrimethoxydecane, methyl group to exemplify propylene glycol diglycidyl ether, oleyl ether, glycidylmethyl benzene Methyl-aminomethyl if at 100~30 heavy 3·amino-aminopropyl-aminoethyl propyl-ureidopropyl-31 - 1354843-based triethoxydecane 'N-ethoxycarbonyl-3 Aminopropyltrimethoxydecane, Ν-ethoxycarbonyl-3-aminopropyltriethoxydecane, N-triethoxydecylpropyltriethylamine, tris-trimethoxydecane Propyl triethylamine, 10-dimethoxydecyl-1,4,7-triazadecane, ι〇·triethoxyindolyl-1,4,7-triazole Heteroane, 9-trimethoxydecyl-3,6-diazadecyl acetate, 9-triethoxydecyl-3,6-diazadecyl acetate, Ν-section 3-aminopropyltrimethoxydecane, Ν·benzyl·3_aminopropyltriethoxydecane, Ν-phenyl-3-aminopropyltrimethoxy sane, Ν-benzene _3_Aminopropyltriethoxydecane, Ν-bis(oxyvinyl)-3-aminopropyltrimethoxy sulphane, N-di Oxyethylene) -3-aminopropyl triethoxy silane-like. The compounding ratio of the functional decane-containing compound is preferably 4 parts by weight or less based on 1 part by weight of the polymer. Examples of the organic solvent constituting the liquid crystal alignment agent of the present invention include 1-methyl-2-pyrrolidone, r·butyrolactone, r-butyrolactam, and ν,ν-dimethylformamidine. Amine, hydrazine, hydrazine-dimethylacetamide, 4-hydroxy-4-methyl-2-pentanone, ethylene glycol monomethyl ether, butyl lactate, butyl acetate, methyl methoxypropionate, Ethyl ethoxypropionate, ethylene glycol methyl ether, ethylene glycol ether, ethylene glycol n-propyl ether, ethylene glycol isopropyl ether, ethylene glycol n-butyl ether (butyl cellosolve), ethylene glycol dimethyl ether , ethylene glycol ethyl ether acetate, diglyme, diethylene glycol diethyl ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monomethyl ether acetate, diethylene glycol monoethyl ether Acetate, 3-butoxy-indole, hydrazine-dimethylpropanamide, 3-methoxy-hydrazine, hydrazine-dimethylpropanamide, 3-hexyloxy-oxime, hydrazine-dimethyl Propionamide 'isoamyl propionate, isoamyl isobutyrate, diisoamyl ether, and the like. Its -32-

1354843 中,3-丁氧基-N,N-二甲基丙醯胺、3-甲氧基-N,N 醯胺、3-己氧基-N,N-二甲基丙醯胺由於顯示良好 而特佳。 本發明之液晶配向劑中固體成分濃度考慮黏 性等而進行選擇,較佳爲1〜重量%的範圍。转 將本發明之液晶配向劑塗敷於基板表面,形成作 向膜的塗膜,當固體成分濃度不足1重量%時, 膜的厚度過小,從而不能得到良好的液晶配向膜 成分濃度超過10重量%時,將導致塗膜厚度過 能得到良好的液晶配向膜,並且,液晶配向劑的 塗敷特性變差。 另外,特佳的固體成分濃度範圍根據向基相 配向劑時所使用的方法而不同。例如,當爲旋璧 佳爲1.5〜4.5重量%的範圍。當使用印刷法時, 體成分濃度爲3〜9重量%的範圍,這樣,可以恒 落在12〜50mPai的範圍。當使用噴墨法時,聘 成分濃度爲1〜5重量%的範圍,這樣可以使溶祕 3〜15mPa,s的範圍。 調製本發明液晶配向劑時的溫度較佳爲〇°C 更佳爲20°C〜60°C。 &lt;液晶顯示元件&gt; 用本發明液晶配向劑製得的液晶顯示元件, 例如以下的方法製造。 -二甲基丙 的印刷性 性、揮發 I句話說, 爲液晶配 導致該塗 ;當固體 ,從而不 占性增大, :塗敷液晶 :法時,特 特佳爲固 ί溶液黏度 ;佳爲固體 i黏度落在 〜200〇C , 可以通過 -33- 1354843 (1)通過平版印刷法、旋塗法或者噴墨印刷法,將本發 明的液晶配向劑塗敷在設有形成圖案的透明導電膜的基板 之一面上’接著’藉由加熱塗敷面形成塗膜。這裏,作爲 基板,可以使用例如浮法玻璃、鈉鈣玻璃等玻璃;聚對苯 二甲酸乙二醇酯 '聚對苯二甲酸丁二醇酯、聚醚颯、聚碳 酸酯、脂環式聚烯烴等之由塑膠所構成之透明基板。作爲 基板之一面上所設置的透明導電膜,可以使用由氧化錫 (SnO〇所構成的NESA膜(美國ppg公司註冊商標)、由氧化 銦—氧化錫(In2〇3 — Sn〇2)所構成的ITO膜等。這些透明導 電膜之圖案形成使用光蝕刻法或預先使用遮罩的方法。.在 液晶配向劑的塗敷時,爲了進一步改善基板表面和透明導 電膜與塗膜的接著性,還可以在基板的該表面上預先塗敷 含官能性矽烷的化合物、含官能性鈦的化合物等。塗敷液 晶配向劑後,爲了防止塗敷的配向劑液體下垂等的目的, 較佳爲進行預備加熱(預烘焙(pre-bake))。預烘焙溫度較佳 爲30〜200°C,更佳爲40〜150°C,特佳爲40〜loot:»然 後,完全除去溶劑,爲了使聚醯胺酸熱醯亞胺化的目的, 進行焙燒(後烘焙(post-bake))製程。該焙燒(後烘焙)溫度較 佳爲80〜300°C,更佳爲120〜250°C。另外,含聚醯胺酸 的本發明之液晶配向劑,通過塗敷後除去有機溶劑,形成 作爲配向膜的塗膜,還可以通過進一步加熱使其進行脫水 閉環,形成進一步醯亞胺化的塗膜。所形成的塗膜的厚度 較佳爲0.001〜lvm,更佳爲0.005〜0.5/zm。 -34- 1354843 (2) 將所形成的塗膜面用纏有由例如尼龍、人造纖維、 棉花等纖維所製成的布的輥進行以一定方向摩擦的打磨處 理。這樣,製成在塗膜上產生了液晶分子配向能的液晶配 向膜。另外,對由本發明之液晶配向劑形成的液晶配向膜, 進行例如日本特開平6 - 222366號公報或日本特開平6 — 281937號公報中所示的部分地照射紫外線而使預傾角改變 的處理,或者進行如日本特開平5 - 1 07 544號公報中所示 的在實施打磨處理後的液晶配向膜表面上部分地形成保護 膜,以與先前打磨處理不同的方向進行打磨處理後,除去 保護膜,進行使液晶配向膜的液晶配向能改變的處理,這 樣能夠改善液晶顯示元件的視野特性。 (3) 製作2片如上形成液晶配向膜的基板,將2片基板 隔著間隙(晶胞間隙‘)相對放置,使各自液晶配向膜的打磨 方向相互垂直或逆平行,將2片基板周邊部位用密封劑貼 合,向由基板表面和密封劑所區隔出的晶胞間隙內注入充 塡液晶,封閉注入孔,構成液晶胞。然後,在液晶胞的外 表面,即構成液晶胞的各基板的另一側面上,貼合偏光片, 使其偏光方向與該基板一面上所形成的液晶配向膜的打磨 方向一致或者垂直,製得液晶顯示元件。 這裏,作爲密封劑,可以使用例如作爲固化劑和間隙 物的含氧化鋁球的環氧樹脂等。 作爲液晶,可以舉出向列型液晶和碟狀型液晶,其中 較佳爲向列型液晶,可以使用例如希夫氏鹼類液晶、氧化 -35- 1354843 偶氮基類液晶、聯苯類液晶、苯基環己烷類液晶、酯類液 晶、三聯苯類液晶、聯苯基環己烷類液晶、嘧啶類液晶、 二氧陸圜類液晶、雙環辛烷類液晶、立方烷類液晶等。此 外,這些液晶中還可以添加例如氯化膽甾醇、膽甾醇壬酸 酯、膽甾醇碳酸酯等膽甾型液晶和以商品名“ C-1 5 ” 、 “CB-15” (默克公司製)銷售的手性劑等而進行使用。並 且,還可以使用對癸氧基苯亞甲基-對胺基-2-甲基丁基肉桂 φ 酸酯等鐵電性液晶。 另外,作爲液晶胞外表面上貼合的偏光片,可以舉出 將聚乙烯醇一邊延伸配向,一邊吸收碘所得的稱作爲Η膜 的偏光膜夾在醋酸纖維素保護膜中而製成的偏光片或者Η 膜自身製成的偏光片。 【實施例】 以下,通過實施例對本發明進行更具體的說明,但是 本發明並不局限於這些實施例。 • [印刷性評價] 準備一側面的整面上形成了 ΙΤΟ膜的 127mm(D)x 127mm(W)Xl.lmm(H)的玻璃基板,將上述實驗中得到的液 晶配向劑通過孔徑爲0.2 μιη的微孔濾器過濾後,用液晶配 向膜塗敷用印刷機(日本寫真印刷(股)製造,Angstromer S -40 L)塗敷於該玻璃基板的透明電極面上。通過設定爲80 °C的加熱板密著式預乾燥機進行乾燥,再在200°C下焙燒 60分鐘,在帶有ITO膜的玻璃基板上形成液晶配向膜。按 -36- 1354843 照以下基準對所得配向膜的不勻進行目測評價。 〇:一點都沒有觀察到不勻。 « △:觀察到一些不句。 X :明顯地觀察到不勻。 [電壓保持率] 在1 67毫秒的時間間隔內,在60°c下給液晶顯示元;{牛 施加5 V的電壓,電壓施加時間爲60微秒,然後測定從電 壓解除至167毫秒後的電壓保持率。測定裝置使用東陽科 技(股)製的VHR-1。 [殘影實驗] 製作如第1圖所示的帶有ITO電極的晶胞。在室溫下 向電極A施加24小時6.0V直流電壓,向電極B施加24 小時0.5V直流電壓。釋放應力後,向電極a、b以nvIn 1-354843, 3-butoxy-N,N-dimethylpropanamide, 3-methoxy-N,N-decylamine, 3-hexyloxy-N,N-dimethylpropionamide is shown Good and excellent. The solid content concentration in the liquid crystal alignment agent of the present invention is selected in consideration of viscosity or the like, and is preferably in the range of 1 to wt%. The liquid crystal alignment agent of the present invention is applied to the surface of the substrate to form a coating film for the film. When the solid content concentration is less than 1% by weight, the thickness of the film is too small, so that a good liquid crystal alignment film component concentration of more than 10% cannot be obtained. When % is used, the coating film thickness is too high to obtain a favorable liquid crystal alignment film, and the coating characteristics of the liquid crystal alignment agent are deteriorated. Further, a particularly preferable solid content concentration range differs depending on the method used in the case of the base phase alignment agent. For example, when it is a spin, it is preferably in the range of 1.5 to 4.5% by weight. When the printing method is used, the body component concentration is in the range of 3 to 9 % by weight, so that it can be kept in the range of 12 to 50 mPai. When the ink jet method is used, the concentration of the component is in the range of 1 to 5 wt%, so that the range of 3 to 15 mPa, s is dissolved. The temperature at which the liquid crystal alignment agent of the present invention is prepared is preferably 〇 ° C or more preferably from 20 ° C to 60 ° C. &lt;Liquid crystal display element&gt; A liquid crystal display element obtained by using the liquid crystal alignment agent of the present invention is produced, for example, by the following method. - Printability of dimethyl propyl acrylate, volatilization I said that the coating is caused by liquid crystal alignment; when it is solid, it does not increase its density; when applying liquid crystal: method, Tetejia is the viscosity of the solution; For the solid i viscosity falling at ~200 〇C, the liquid crystal alignment agent of the present invention can be applied to the transparent layer formed by patterning by lithography, spin coating or inkjet printing. On one side of the substrate of the conductive film, 'subsequent' is formed by heating the coated surface to form a coating film. Here, as the substrate, for example, glass such as float glass or soda lime glass; polyethylene terephthalate 'polybutylene terephthalate, polyether oxime, polycarbonate, and alicyclic poly A transparent substrate made of plastic such as olefin. As the transparent conductive film provided on one surface of the substrate, a tin oxide film (NSA film made of SnO〇 (registered trademark of American PPG Co., Ltd.) and indium oxide-tin oxide (In2〇3 — Sn〇2) can be used. ITO film, etc. The pattern of these transparent conductive films is formed by photolithography or a mask in advance. In order to further improve the adhesion between the substrate surface and the transparent conductive film and the coating film during the application of the liquid crystal alignment agent, Further, a functional decane-containing compound, a functional titanium-containing compound, or the like may be applied to the surface of the substrate. After the liquid crystal alignment agent is applied, it is preferably carried out for the purpose of preventing the applied alignment agent liquid from sagging or the like. Preheating (pre-bake). The prebaking temperature is preferably 30 to 200 ° C, more preferably 40 to 150 ° C, particularly preferably 40 to loot: » then, completely remove the solvent, in order to make the poly For the purpose of hydrazine imidization, a calcination (post-bake) process is carried out. The calcination (post-baking) temperature is preferably from 80 to 300 ° C, more preferably from 120 to 250 ° C. , the liquid of the invention containing polylysine The coating agent removes the organic solvent by coating to form a coating film as an alignment film, and further dehydrates and closes the film by further heating to form a coating film which is further imidized. The thickness of the formed coating film is preferably 0.001 to lvm, more preferably 0.005 to 0.5/zm. -34- 1354843 (2) The formed coating film surface is made of a roller wrapped with a cloth made of fibers such as nylon, rayon, cotton or the like. In the case of the liquid crystal alignment film in which the alignment property of the liquid crystal molecules is generated on the coating film, the liquid crystal alignment film formed of the liquid crystal alignment agent of the present invention is disclosed, for example, in Japanese Laid-Open Patent Publication No. Hei 6-222366. Or a process of partially irradiating ultraviolet rays to change a pretilt angle as shown in Japanese Laid-Open Patent Publication No. Hei 6-281937, or performing a liquid crystal alignment after performing a sanding process as shown in Japanese Laid-Open Patent Publication No. Hei No. Hei No. Hei. A protective film is partially formed on the surface of the film, and after being polished in a direction different from the previous polishing process, the protective film is removed, and the liquid crystal alignment of the liquid crystal alignment film can be changed. The treatment can improve the visual field characteristics of the liquid crystal display device. (3) Two substrates on which the liquid crystal alignment film is formed are formed, and the two substrates are placed opposite each other with a gap (cell gap ') to polish the respective liquid crystal alignment films. The directions are perpendicular or anti-parallel to each other, and the peripheral portions of the two substrates are bonded together with a sealant, and the liquid crystal is filled into the cell gap separated from the surface of the substrate and the sealant, and the injection holes are closed to form a liquid crystal cell. Then, On the outer surface of the liquid crystal cell, that is, on the other side surface of each of the substrates constituting the liquid crystal cell, the polarizer is bonded so that the polarizing direction thereof coincides with or perpendicular to the rubbing direction of the liquid crystal alignment film formed on one side of the substrate, thereby obtaining a liquid crystal. Display component. Here, as the sealant, for example, an alumina ball-containing epoxy resin or the like which is a curing agent and a spacer can be used. Examples of the liquid crystal include a nematic liquid crystal and a disk-shaped liquid crystal. Among them, a nematic liquid crystal is preferable, and for example, a Schiff base liquid crystal, an oxidized -35-1354843 azo liquid crystal, or a biphenyl liquid crystal can be used. A phenylcyclohexane liquid crystal, an ester liquid crystal, a terphenyl liquid crystal, a biphenylcyclohexane liquid crystal, a pyrimidine liquid crystal, a dioxane liquid crystal, a bicyclooctane liquid crystal, a cuba liquid crystal or the like. Further, cholesteric liquid crystals such as cholesteryl chloride, cholesteryl phthalate, and cholesteryl carbonate may be added to these liquid crystals, and the trade names "C-1 5" and "CB-15" (manufactured by Merck & Co., Inc.) may be added. The chiral agent sold, etc. is used. Further, a ferroelectric liquid crystal such as p-methoxybenzylidene-p-amino-2-methylbutylcinnamate φ acid ester can also be used. In addition, the polarizing film to be bonded to the outer surface of the liquid crystal may be a polarizing film called a ruthenium film obtained by absorbing iodine while extending the alignment of the polyvinyl alcohol, and the polarizing film is formed by sandwiching the cellulose acetate protective film. A polarizer made of a film or a film itself. [Examples] Hereinafter, the present invention will be more specifically described by way of Examples, but the present invention is not limited to these Examples. • [Printability evaluation] A 127 mm (D) x 127 mm (W) Xl.lmm (H) glass substrate on which the enamel film was formed on one side was prepared, and the liquid crystal alignment agent obtained in the above experiment was passed through a pore diameter of 0.2. After filtering through a micropore filter of μιη, it was applied to a transparent electrode surface of the glass substrate by a liquid crystal alignment film coating printing machine (manufactured by Nippon Photo Printing Co., Ltd., Angstromer S-40L). The film was dried by a hot plate preheater set at 80 ° C, and baked at 200 ° C for 60 minutes to form a liquid crystal alignment film on a glass substrate with an ITO film. The unevenness of the obtained alignment film was visually evaluated according to the following criteria according to -36 to 1354843. 〇: No unevenness was observed at all. « △: Some sentences are observed. X: Unevenness was clearly observed. [Voltage Retention Rate] The liquid crystal display element was given at 60 ° C in a time interval of 1 67 msec; {5 V voltage was applied to the cow, the voltage application time was 60 μsec, and then the voltage was released from the voltage release to 167 msec. Voltage retention rate. The measuring device used VHR-1 manufactured by Dongyang Science and Technology Co., Ltd. [After image experiment] A unit cell with an ITO electrode as shown in Fig. 1 was produced. A DC voltage of 6.0 V was applied to the electrode A for 24 hours at room temperature, and a DC voltage of 0.5 V was applied to the electrode B for 24 hours. After releasing the stress, the electrodes a and b are nv

的梯度施加0.1〜5.0V直流電壓。通過各電壓下電極a、B 的亮度差判斷殘影特性。當亮度差大時,殘影特性判斷爲 差。 〇:完全沒有發現亮度差。 △:存在一定的亮度差。 &lt;特定化合物的合成 -37- 1354843 催化劑 h2nO~〇-nh2 A-l 本反應中所用的鎳催化劑由於與大氣中的氧氣和水蒸 氣反應而容易失去活性。因此,反應中所用的溶劑和試劑 通過預先蒸餾和再結晶處理除去雜質後再使用。聚合反應 在氮氣環境下進行。 聚合反應按照文獻方法(T. Kanbara,J. Polym. Sci. Part— A,Polym. Chem·,38,4 194(2000))進行。向內部用氮 氣換氣過的四頸燒瓶中,加入4,4’ -二氯聯苯(lmmol)、聯 苯胺(lmmol)和甲苯15ml,攪拌幾分鐘後,在室溫下加入3 級丁氧基鈉 288mg(3mmol)、二(1,5-環辛二燃)鎳 (0)(Ni(cod)2)28mg(0. lmmol)以及 1,1,-二(二苯基膦)二茂 鐵(DPPF)166mg(〇.3mmol)。將該反應液在氮氣環境下一邊攪 拌一邊加熱至60°C,使反應開始。使其在60°C下反應24 小時後’加入極少量聯苯胺(0.05 mmol),使聚合物末端用聯 苯胺封閉’從而使聚合終止。冷卻至室溫後,將反應溶液 注入到200ml氨水與甲醇的混合溶液中,濾出所得的沉澱 物,將回收的沉澱物用甲醇與乙醚進一步洗滌,得到特定 化合物A - 1。 &lt;特定化合物的合成2&gt; -38- 1354843The gradient is applied with a DC voltage of 0.1 to 5.0 volts. The afterimage characteristics were judged by the difference in luminance between the electrodes a and B at the respective voltages. When the luminance difference is large, the afterimage characteristic is judged to be poor. 〇: No difference in brightness was found. △: There is a certain difference in brightness. &lt;Synthesis of a specific compound -37- 1354843 Catalyst h2nO~〇-nh2 A-l The nickel catalyst used in the reaction is easily deactivated by reaction with oxygen and water vapor in the atmosphere. Therefore, the solvent and the reagent used in the reaction are removed by pre-distillation and recrystallization to remove impurities. The polymerization was carried out under a nitrogen atmosphere. The polymerization was carried out according to the literature method (T. Kanbara, J. Polym. Sci. Part-A, Polym. Chem., 38, 4 194 (2000)). To a four-necked flask ventilated with nitrogen, 4,4'-dichlorobiphenyl (1 mmol), benzidine (1 mmol) and 15 ml of toluene were added. After stirring for a few minutes, a 3-stage butoxide was added at room temperature. Base sodium 288 mg (3 mmol), bis(1,5-cyclooctanedione) nickel (0) (Ni(cod) 2) 28 mg (0.1 mmol) and 1,1,-bis(diphenylphosphine) ferrocene Iron (DPPF) 166 mg (〇. 3 mmol). The reaction solution was heated to 60 ° C while stirring under a nitrogen atmosphere to start the reaction. After reacting at 60 ° C for 24 hours, 'a small amount of benzidine (0.05 mmol) was added, and the polymer terminal was blocked with benzidine' to terminate the polymerization. After cooling to room temperature, the reaction solution was poured into a mixed solution of 200 ml of aqueous ammonia and methanol, and the resulting precipitate was filtered off, and the recovered precipitate was further washed with methanol and diethyl ether to give the compound A-1. &lt;Synthesis of a specific compound 2&gt; -38- 1354843

A-2 特定化合物A_2包括如上所示的多種結構。 在三頸燒瓶中將特定化合物A_1的THF溶液與過量 的胺基鈉進行混合。使該溶液加熱回流2小時後,冷卻反 應溶液’滴加過量的環氧溴丙烷。加熱至80°c,繼續攪拌 6小時。過濾反應溶液,濾液依次用氯仿/1() %鹽酸水溶液、 飽和食鹽水進行分液洗滌。將有機層用無水硫酸鎂乾燥, 蒸餾除去溶劑。將殘留物用甲醇進行再沉澱,得到特定化 合物A — 2。 聚醯亞胺合成例1 將作爲四羧酸二酸酐的2,3,5-三羧基環戊基醋酸二酸 酐 li2g(0.50 莫耳)和 1,3,3&amp;,4,5,91)-六氫-8-甲基-5-(四氫 -2,5-二氧代-3-呋喃基)-萘[1,2-(:]呋喃-1,3-二酮 157g(0.50 莫耳)’作爲二胺化合物的對-苯二胺96g(0.89莫耳)、 3,3’ -(四甲基二矽氧烷-13_二基)二(丙胺)25g(〇.1()莫耳) 和3,6-二(4-胺基苯甲醯氧基)膽甾烷i3g(0.020莫耳)、作爲 -39- 1354843 單胺的正十八烷基胺8.1g(0.030莫耳)溶於960g N -甲基- 2-吡咯烷酮中,使其在60°C下反應6小時。將得到的聚醯胺 酸溶液分取少量,加入NMP,在固體成分濃度1〇 %的溶液 下測定黏度,爲60mPas。接著,在所得之聚醯胺酸溶液中 追加2700g N -甲基-2-吡咯烷酮,添加396g吡啶和409g醋 酸酐,在1 1 0°C下脫水閉環4小時。醯亞胺化反應後,將體 系內的溶劑以新的r-丁內酯進行溶劑置換(藉由本操作, 將醯亞胺化反應中使用的吡啶、醋酸酐除去至體系外),得 到約2000g固體成分濃度15wt%、固體成分濃度10%時(r-丁內酯溶液)的溶液黏度爲70mPa‘s、醯亞胺化率約95 %的 醯亞胺化聚合物(其作爲“聚醯亞胺(a— 1)”)溶液。 聚醯亞胺合成例2 將作爲四羧酸二酸酐的2,3,5 -三羧基環戊基醋酸二酸 酐224g(1.0莫耳),作爲二胺化合物的對-苯二胺i〇gg(1〇 莫耳)和3,5-二胺基苯甲酸膽甾烷基酯7.8g((K015莫耳)溶於 3039g N -甲基-2 -吡咯烷酮中,使其在60°C下反應6小時, 藉以得到溶液黏度約爲260mPa.s的聚酸胺酸溶液。接著, 在所得之聚醯胺酸溶液中追加2700g N-甲基-2-吡咯烷酮, 添加396g毗啶和306g醋酸酐,在1 1(TC下脫水閉環4小時。 醯亞胺化反應後,在體系內的溶劑以新的r -丁內酯進行溶 劑置換(藉由本操作,將醯亞胺化反應中使用的吡啶、醋酸 酐除去至體系外),得到約3000g固體成分濃度約9.0wt%、 固體成分濃度10%時(r-丁內酯溶液)的溶液黏度爲 -40- 1354843 250mPas、醒亞胺化率約5i%的醯亞胺化聚合物(其作爲 釀亞fee化聚合物(a — 2)”)溶液。 聚醯胺酸合成例1 將作爲四羧酸二酸酐的12,3,4_環丁烷四羧酸二酸酐 196g(1.0莫耳),作爲二胺化合物的2,2,·二甲基-4,4,·二 胺基聯苯212g(l.〇莫耳)溶於37〇g N_甲基_2吡咯烷酮、 3 3〇〇g之r-丁內酯中,使其在4〇〇c下反應3小時,得到溶 液黏度160mPa.s的聚醯胺酸(其作爲“聚醯胺酸(b—丨)”) 溶液約3 700g。 聚醯胺酸合成例2 將作爲四羧酸二酸酐的1,2,3,4 -環丁烷四羧酸二酸酐 95g(0.50莫耳)、均苯四酸二酸酐i〇9g(〇5〇莫耳),作爲二 胺化合物的2,7-二胺基芴196£(1.0莫耳)溶於23〇£1^-甲基 -2-吡略院酮、2060g之r-丁內酯中,使其在4〇°C下反應3 小時’追加1 3 5 0 g之r · 丁內酯’得到固體成分濃度1 〇 %下 的溶液黏度爲125mPa‘s的聚醯胺酸(其作爲“聚醯胺酸(b —2)” )溶液約 3600g。 實施例1 將聚醯亞胺合成例1中製得的聚醯亞胺(a _ 1)和聚醯 胺酸合成例1中製得的聚醯胺酸(b — 1)以構成爲聚醯亞胺: 聚醯胺酸= 20:80(重量比)般溶於r -丁內酯/N -甲基-2-吡咯 烷酮/丁基溶纖劑混合溶劑(重量比71/1 7/12)中。向該溶液 中分別相對於 100重量份上述聚合物加入 2重量份 -41 - 1354843 Ν,Ν,Ν’ ,N’ -四縮水甘油基-4,4’ -二胺基二苯基甲烷,進 一步地相對於100重量份上述聚合物加入10重量份特定化 合物A— 1,製成固體成分濃度爲3.5重量%的溶液和6.0 重量%的溶液。將各溶液充分攪拌後,用孔徑爲l^m的濾 器過濾,調製出本發明的液晶配向劑。 使用旋塗機將上述液晶配向劑中固體成分濃度爲3.5 重量%的溶液塗敷於厚度爲1mm的玻璃基板的一面上所設 置的ITO膜製透明導電膜上(轉速:2500rpm,塗敷時間:1 分鐘),在200 °C下乾燥1小時,形成乾燥膜厚爲〇.〇8 a m 的覆膜。使用裝有纏繞人造纖維製之布的輥的打磨機,在 輥轉速爲400 rpm、操作臺移動速度爲3cm/秒,絨毛押入 長度爲0.4mm的條件下,對該覆膜進行打磨處理。將上述 液晶配向膜塗敷基板在超純水中以超音波洗淨1分鐘後, 在100°C的乾淨烤箱中乾燥10分鐘。然後,在一對透明電 極/透明電極基板的上述液晶配向膜塗敷基板的具有液晶 配向膜的各外緣上,塗敷加入了直徑爲5.的氧化鋁球 的環氧樹脂接著劑,然後,使液晶配向膜面相對地重合並 壓合,使接著劑固化。接著,通過液晶注入口向基板間塡 充向列型液晶(默克公司製,MLC-622 1),然後用丙烯酸類 光固化黏合劑將液晶注入口封閉,在基板外側的兩面上貼 合偏光板,製成TN液晶顯示元件。按照以上所述的方法進 行對所得液晶顯示元件的電壓保持率評價和殘影評價。 另外,使用固體成分濃度爲6.0重量%的溶液,按照以 -42- 1354843 上所述的方法進行印刷性評價。 實施例2〜4 除了聚醯亞胺、聚醯胺酸、特定化合物使用表1中所 示的物質以外,按照與實施例1同樣的流程進行。 實施例5 將聚醯亞胺合成例2中製得的聚醯亞胺(a - 2)溶於N-甲基-2-吡略烷酮/丁基溶纖劑混合溶劑(重量比50/50)中, φ 相對於100重量份聚合物加入2重量份N,N,N’ ,N’ -四縮 水甘油基-4,4’ -二胺基二苯基甲烷,相對於100重量份聚 合物加入10重量份特定化合物A— 1,製成固體成分濃度 爲3.5重量%的溶液和6.0重量%的溶液。將各溶液充分攪 拌後,用孔徑爲1 # m的濾器過濾,調製出本發明的液晶配 向劑。液晶顯示元件的製作方法、液晶顯示元件的評價方 法以及配向劑印刷性的評價方法按照與實施例1相同的方 法進行。 • 實施例6 除了特定化合物使用表1中所示的物質以外’按照與 實施例5同樣的流程進行。 比較例1〜2 除了聚醯亞胺、聚醯胺酸使用表1中所示的物質’並 且不添加特定化合物以外,按照與實施例1同樣的流程進 行。 比較例3 -43- 1354843 除了不添加特定化合物以外,按照與實施例5同樣的 流程進行。 比較例4〜5 除了聚醯亞胺、聚醯胺酸使用表1中所示的物質,並 使用下述結構的化合物(化合物X)代替特定化合物以外,按 照與實施例1同樣的流程進行。化合物X按照日本特開2〇〇〇 —446 8 3號中所述的方法合成^A-2 The specific compound A_2 includes various structures as shown above. A solution of the specific compound A_1 in THF was mixed with an excess of sodium amine in a three-necked flask. After the solution was heated to reflux for 2 hours, the reaction solution was cooled to drop an excess of epibromohydrin. Heat to 80 ° C and continue stirring for 6 hours. The reaction solution was filtered, and the filtrate was washed with chloroform / 1 (%) aqueous hydrochloric acid and saturated brine. The organic layer was dried over anhydrous magnesium sulfate and the solvent was evaporated. The residue was reprecipitated with methanol to give the specific compound A-2. Polyimine synthesis example 1 2,3,5-tricarboxycyclopentyl acetic acid dianhydride as a tetracarboxylic dianhydride li2g (0.50 mol) and 1,3,3&amp;, 4,5,91)- Hexahydro-8-methyl-5-(tetrahydro-2,5-dioxo-3-furanyl)-naphthalene [1,2-(:]furan-1,3-dione 157 g (0.50 mol) ''p-phenylenediamine as a diamine compound 96g (0.89 mol), 3,3'-(tetramethyldioxanthene-13-diyl) bis(propylamine) 25g (〇.1() Mo Ear) and 3,6-bis(4-aminobenzimidyloxy)cholestane i3g (0.020 mol), n-octadecylamine as a -39-1354843 monoamine 8.1 g (0.030 mol) Dissolved in 960g of N-methyl-2-pyrrolidone and allowed to react at 60 ° C for 6 hours. The obtained polyamidamine solution was divided into small amounts, added with NMP, and determined under a solid concentration of 1% by weight. The viscosity was 60 mPas. Next, 2700 g of N-methyl-2-pyrrolidone was added to the obtained polyamic acid solution, and 396 g of pyridine and 409 g of acetic anhydride were added, and the mixture was dehydrated and closed at 110 ° C for 4 hours. After the reaction, the solvent in the system is replaced with a new r-butyrolactone (by this operation, the oxime is imidized) The pyridine and acetic anhydride used in the reaction are removed to the outside of the system to obtain a solid concentration of 15% by weight and a solid concentration of 10% (r-butyrolactone solution). The solution viscosity is 70 mPa's, and the sulfhydrylation rate is 醯. About 95% of the ruthenium iodide polymer (as a "polyimine (a-1)") solution. Polyimine synthesis example 2 2,3,5-tricarboxyl group as tetracarboxylic dianhydride 224 g (1.0 mol) of cyclopentyl acetic acid dianhydride, p-phenylenediamine i 〇 gg (1 〇 mol) as a diamine compound and 7.8 g of 3,5-diaminobenzoic acid cholesteryl ester ( (K015 Moer) was dissolved in 3039 g of N-methyl-2-pyrrolidone and allowed to react at 60 ° C for 6 hours to obtain a polyamic acid solution having a solution viscosity of about 260 mPa·s. 2700 g of N-methyl-2-pyrrolidone was added to the polyaminic acid solution, 396 g of pyridinium and 306 g of acetic anhydride were added, and the mixture was dehydrated and closed for 4 hours at 1 TC. After the hydrazine imidization reaction, the solvent in the system was The new r-butyrolactone is subjected to solvent replacement (by this operation, the pyridine and acetic anhydride used in the oxime imidization reaction are removed to the outside of the system) to obtain about 3,000 g of solid. When the concentration of the body component is about 9.0 wt%, the concentration of the solid component is 10% (r-butyrolactone solution), the solution viscosity is -40 - 1354843 250 mPas, and the yttrium imidization polymer is about 5 i%. Brewed Fee polymer (a-2)") solution. Polylysine Synthesis Example 1 196 g (1.0 mol) of 12,3,4-cyclobutanetetracarboxylic acid dianhydride as a tetracarboxylic acid dianhydride, as a diamine compound of 2,2,-dimethyl- 4,4,·diaminobiphenyl 212g (l. oxime) is dissolved in 37〇g N_methyl-2-pyrrolidone, 3 3〇〇g of r-butyrolactone, so that it is at 4〇〇 The reaction was carried out for 3 hours at c to obtain a solution of polylysine having a solution viscosity of 160 mPa·s (as a "poly-proline (b-oxime)") solution of about 3 700 g. Polylysine Synthesis Example 2 1,2,3,4-cyclobutanetetracarboxylic acid dianhydride as tetracarboxylic acid dianhydride 95 g (0.50 mol), pyromellitic dianhydride i 〇 9 g (〇5) 2,7-diamino 芴 196 £ (1.0 mol) as a diamine compound dissolved in 23 〇£1^-methyl-2-pyrrolidone, 2060 g of r-butyrolactone In the reaction, the reaction was carried out at 4 ° C for 3 hours to add 1 3 50 g of r · butyrolactone to obtain a polyamic acid having a solution concentration of 125 mPa's at a solid concentration of 1 〇% (as The "polyglycine (b-2)") solution was about 3600 g. Example 1 Polyimine (a _ 1) prepared in Polyimine Synthesis Example 1 and polylysine (b-1) obtained in Polyamine Synthesis Example 1 were constructed as polyfluorene Imine: Polyamine: 20:80 (by weight) dissolved in r-butyrolactone/N-methyl-2-pyrrolidone/butyl cellosolve mixed solvent (weight ratio 71/1 7/12). To the solution, 2 parts by weight of -41 - 1354843 Ν, Ν, Ν', N'-tetraglycidyl-4,4'-diaminodiphenylmethane were further added to 100 parts by weight of the above polymer, respectively. 10 parts by weight of the specific compound A-1 was added to 100 parts by weight of the above polymer to prepare a solution having a solid concentration of 3.5% by weight and a 6.0% by weight solution. After the respective solutions were thoroughly stirred, they were filtered through a filter having a pore size of 1 μm to prepare a liquid crystal alignment agent of the present invention. A solution having a solid concentration of 3.5% by weight in the above liquid crystal alignment agent was applied onto a transparent conductive film made of an ITO film provided on one surface of a glass substrate having a thickness of 1 mm using a spin coater (rotation speed: 2,500 rpm, coating time: After 1 minute), it was dried at 200 ° C for 1 hour to form a film having a dry film thickness of 〇.〇8 am. The film was subjected to a sanding treatment using a sanding machine equipped with a roll of rayon-made cloth, at a roll speed of 400 rpm, a table moving speed of 3 cm/sec, and a fluffing length of 0.4 mm. The above liquid crystal alignment film-coated substrate was ultrasonically washed in ultrapure water for 1 minute, and then dried in a clean oven at 100 ° C for 10 minutes. Then, on each of the outer edges of the liquid crystal alignment film of the liquid crystal alignment film coating substrate of the pair of transparent electrode/transparent electrode substrates, an epoxy resin adhesive to which an alumina ball having a diameter of 5. is applied is applied, and then The liquid crystal alignment film surface is relatively recombined and pressed to cure the adhesive. Next, a nematic liquid crystal (MLC-622 1 manufactured by Merck & Co., Inc.) is filled between the substrates through a liquid crystal injection port, and then the liquid crystal injection port is closed with an acrylic photocurable adhesive, and polarized light is applied to both sides of the substrate. The board is made of a TN liquid crystal display element. The voltage holding ratio evaluation and the afterimage evaluation of the obtained liquid crystal display element were carried out in accordance with the method described above. Further, using a solution having a solid concentration of 6.0% by weight, the printability was evaluated in accordance with the method described in -42 to 1354843. Examples 2 to 4 were carried out in the same manner as in Example 1 except that the polyimine, the polyamic acid, and the specific compound were used as shown in Table 1. Example 5 Polyimine (a-2) prepared in Polyimine Synthesis Example 2 was dissolved in a mixed solvent of N-methyl-2-pyrrolidone/butyl cellosolve (weight ratio 50/50) Wherein φ is added to 2 parts by weight of N,N,N',N'-tetraglycidyl-4,4'-diaminodiphenylmethane relative to 100 parts by weight of the polymer, relative to 100 parts by weight of the polymer. 10 parts by weight of the specific compound A-1 was prepared as a solution having a solid concentration of 3.5% by weight and a solution of 6.0% by weight. After the respective solutions were thoroughly stirred, they were filtered through a filter having a pore size of 1 m to prepare a liquid crystal alignment agent of the present invention. The method for producing a liquid crystal display device, the method for evaluating a liquid crystal display device, and the method for evaluating the printability of an alignment agent were carried out in the same manner as in Example 1. • Example 6 The procedure was the same as in Example 5 except that the specific compounds were used in the materials shown in Table 1. Comparative Examples 1 to 2 The same procedures as in Example 1 were carried out except that the materials shown in Table 1 were used for the polyimine and polyamic acid without adding a specific compound. Comparative Example 3 - 43 - 1354843 The procedure was the same as in Example 5 except that no specific compound was added. Comparative Examples 4 to 5 The same procedures as in Example 1 were carried out except that the materials shown in Table 1 were used as the polyimine and polylysine, and the compound (compound X) having the following structure was used instead of the specific compound. Compound X is synthesized according to the method described in JP-A No. 2,446-8 3

化合物X 比較例6 除了加入化合物X代替特定化合物以外,按照與實施 例5同樣的流程進行。 比較例7〜8 除了聚醯亞胺、聚醯胺酸使用表1中所示的物質,並 ® 使用下述結構的化合物(化合物Y)代替特定化合物以外,按 照與實施例1同樣的流程進行。化合物γ按照W0 2002/100949中所述的方法合成。其分子量Mn = 15000, Mw =30000 » 比較例9 除了加入化合物γ代替特定化合物以外,按照與實施 例5同樣的流程進行》 -44- 1354843Compound X Comparative Example 6 The same procedure as in Example 5 was carried out except that Compound X was added instead of the specific compound. Comparative Examples 7 to 8 The same procedures as in Example 1 were carried out except that the materials shown in Table 1 were used for the polyimine and the polyamine, and the compound (compound Y) having the following structure was used instead of the specific compound. . Compound γ was synthesized according to the method described in WO 2002/100949. Its molecular weight Mn = 15000, Mw = 30000 » Comparative Example 9 The same procedure as in Example 5 was carried out except that the compound γ was added instead of the specific compound. -44- 1354843

表1 聚醯亞胺 聚醯胺酸 特定化合物 電壓保持率 殘影 印刷性 實施例1 a—1 b-1 特定化合物A-1 &gt;99% 〇 〇 實施例2 a—1 b-1 特定化合物A—2 &gt;99% 〇 〇 實施例3 a—1 b-2 特定化合物A-1 &gt;99% 〇 〇 實施例4 a—1 b-2 特定化合物A-2 &gt;99% 〇 〇 實施例5 a-2 — 特定化合物A—1 &gt;99% 〇 〇 實施例6 a-2 — 特定化合物A—2 &gt;99% 〇 〇 比較例1 a—1 b-1 4πτ ιΜΤ: &gt;99% Δ 〇 比較例2 a—1 b-2 Μ &gt;99% △ 〇 比較例3 a-2 — Μ /m &gt;99% Δ 〇 比較例4 a—1 b-1 化合物X 98% Δ 〇 比較例5 a—1 b-2 化合物X 98% Δ 〇 比較例6 a-2 — 化合物X 98% Δ 〇 比較例7 a—1 b-1 化合物Y 98% 〇 X 比較例8 a—1 b-2 化合物Y 98% 〇 X 比較例9 a-2 — 化合物Y 98% 〇 X 【圖式簡單說明】 第1圖爲殘影試驗評價而製作的帶有ITO電極的晶胞。 【主要元件符號說明】 Μ 。 /\\\ -45-Table 1 Polyimine polyimine specific compound voltage retention rate afterimage printing Example 1 a-1 b-1 specific compound A-1 &gt; 99% 〇〇 Example 2 a-1 b-1 specific compound A-2 &gt; 99% 〇〇 Example 3 a-1 b-2 Specific compound A-1 &gt; 99% 〇〇 Example 4 a-1 b-2 Specific compound A-2 &gt; 99% 〇〇Implementation Example 5 a-2 - Specific Compound A-1 &gt; 99% 〇〇 Example 6 a-2 - Specific Compound A-2 &gt; 99% 〇〇 Comparative Example 1 a-1 b-1 4πτ ιΜΤ: &gt;99 % Δ 〇 Comparative Example 2 a-1 b-2 Μ &gt;99% △ 〇Comparative Example 3 a-2 — Μ /m &gt;99% Δ 〇Comparative Example 4 a-1 b-1 Compound X 98% Δ 〇 Comparative Example 5 a-1 b-2 Compound X 98% Δ 〇 Comparative Example 6 a-2 - Compound X 98% Δ 〇 Comparative Example 7 a-1 b-1 Compound Y 98% 〇X Comparative Example 8 a-1 b -2 Compound Y 98% 〇X Comparative Example 9 a-2 - Compound Y 98% 〇X [Simplified description of the drawing] Fig. 1 shows a unit cell with an ITO electrode prepared by evaluation of the residual image test. [Main component symbol description] Μ . /\\\ -45-

Claims (1)

13548431354843 十、申請專利範圍: 1·一種液晶配向劑’其特徵在於含有下述式(1)表示的化合 物,X. Patent application scope: 1. A liquid crystal alignment agent' characterized by containing a compound represented by the following formula (1), (式中,Ri〜R8各自獨立地爲氫原子、院基或院氧基, R9〜Ru各自獨立地爲氫原子、芳香族基團或脂肪族基 團’ A爲氫原子或脂肪族基團,η爲1〜1〇〇的整數)。 2 _如申請專利範圍第1項之液晶配向劑,其中式(I)中,r , 〜R8各自獨立地爲氫原子、碳數爲1〜6的烷基或者碳數 爲1〜6的院氧基,R;»〜Ri2均爲氮原子,A爲氮原子,且 η爲1〜100的整數。 3 ·如申請專利範圍第1項之液晶配向劑,其中式(I)中的R, 〜R8各自獨立地爲氫原子、碳數爲1〜6的烷基或者碳數 爲1〜6的烷氧基,R9和R&quot;爲芳香族基團,Ri〇和Ru爲 氫原子或脂肪族基團,A爲氫原子或脂肪族基團,η爲1 〜100的整數。 4.如申請專利範圍第1項之液晶配向劑’其中式⑴中的Rl 〜Rs各自獨立地爲氫原子、碳數爲丨〜6的烷基或者碳數 爲1〜6的烷氧基,R9和Rm爲芳香族基團’ Ri。和爲 氫原子或含環氧基的脂肪族基團’ A爲氫原子或含環氧基 的脂肪族基團,η爲1〜1〇〇的整數。 -46- 1354843 5. —種液晶配向劑,其特徵在於含有由如申請專利範圍第2 項之化合物與四羧酸二酸酐反應所得的聚醯胺酸聚合 物。 6. 如申請專利範圍第1至5項中任一項之液晶配向劑,其 還含有從由下述式(I - 1)表示的重複單元所構成的聚醯 胺酸和由下述式(I- 2)表示的重複單元所構成的聚醯亞 胺構成的群組中選出的至少一種聚合物, HOOQ ΌΟΟΗ(wherein, Ri to R8 are each independently a hydrogen atom, a group or an aristocratic group, and R9 to Ru are each independently a hydrogen atom, an aromatic group or an aliphatic group. A is a hydrogen atom or an aliphatic group. , η is an integer of 1 to 1 )). 2 _ The liquid crystal alignment agent of claim 1, wherein in the formula (I), r, R8 are each independently a hydrogen atom, an alkyl group having 1 to 6 carbon atoms or a carbon number of 1 to 6 The oxy group, R;»~Ri2 are each a nitrogen atom, A is a nitrogen atom, and η is an integer of from 1 to 100. 3. The liquid crystal alignment agent of claim 1, wherein R, R to R8 in the formula (I) are each independently a hydrogen atom, an alkyl group having 1 to 6 carbon atoms or an alkyl group having 1 to 6 carbon atoms; The oxy group, R9 and R&quot; are aromatic groups, Ri 〇 and Ru are hydrogen atoms or aliphatic groups, A is a hydrogen atom or an aliphatic group, and η is an integer of from 1 to 100. 4. The liquid crystal alignment agent of the first aspect of the invention, wherein R1 to Rs in the formula (1) are each independently a hydrogen atom, an alkyl group having a carbon number of 丨6 or an alkoxy group having a carbon number of 1 to 6, R9 and Rm are aromatic groups 'Ri. And the hydrogen atom or the epoxy group-containing aliphatic group 'A' is a hydrogen atom or an epoxy group-containing aliphatic group, and η is an integer of 1 to 1 Å. -46- 1354843 5. A liquid crystal alignment agent comprising a polyphthalic acid polymer obtained by reacting a compound of the second aspect of the patent application with a tetracarboxylic acid dianhydride. 6. The liquid crystal alignment agent according to any one of claims 1 to 5, further comprising a polylysine composed of a repeating unit represented by the following formula (I-1) and having the following formula ( I-2) at least one polymer selected from the group consisting of polyimine composed of repeating units, HOOQ ΌΟΟΗ (X -4- hnoc conh—q1- 中 其(X -4- hnoc conh-q1- medium 團 基 -機N- 有 o=c\ /c=o 的|/\ Q2- 團 基 機 有 的 價 2 爲 Q 且 在 團徵 基特 機其 有’ 的件 價元 4 示 爲顯 P 晶 ’ 液 中種 其一 且 於 卜範 團利 基專 機請 有申 的如 價用 2 使 爲有 Q 具 向 配 晶 液 的 得 製 而 劑 向 配 晶 液 之 項 1 任 中 項 6 至 I 第。 圍膜 -47-团基-机N- has /===================================================================================================== 'In the liquid, one of the liquids and one of the special planes of the Bufan group, please use the price of 2, so that there is a Q to the liquid crystal solution, and the agent to the liquid crystal item 1 No. 6 to I . Perimembrane -47-
TW096135644A 2006-09-26 2007-09-26 Liquid crystal alignment agent and liquid crystal TWI354843B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006260858 2006-09-26

Publications (2)

Publication Number Publication Date
TW200821716A TW200821716A (en) 2008-05-16
TWI354843B true TWI354843B (en) 2011-12-21

Family

ID=39255733

Family Applications (1)

Application Number Title Priority Date Filing Date
TW096135644A TWI354843B (en) 2006-09-26 2007-09-26 Liquid crystal alignment agent and liquid crystal

Country Status (3)

Country Link
KR (1) KR20080028318A (en)
CN (1) CN100549786C (en)
TW (1) TWI354843B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5360356B2 (en) * 2008-05-26 2013-12-04 Jsr株式会社 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
JP5668922B2 (en) * 2010-03-01 2015-02-12 Jsr株式会社 Liquid crystal aligning agent and liquid crystal display element
CN103026291B (en) * 2010-06-10 2015-08-19 日产化学工业株式会社 Aligning agent for liquid crystal, liquid crystal orientation film and liquid crystal display cells
CN117148630A (en) * 2018-03-19 2023-12-01 日产化学株式会社 Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element

Also Published As

Publication number Publication date
KR20080028318A (en) 2008-03-31
CN100549786C (en) 2009-10-14
CN101153996A (en) 2008-04-02
TW200821716A (en) 2008-05-16

Similar Documents

Publication Publication Date Title
TWI356934B (en) Liquid crystal alignment agent and liquid crystal
TWI427375B (en) Vertical alignment mode liquid crystal alignment agent and liquid crystal display device
TWI504675B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display device
TWI485182B (en) Liquid-crystal alignment material, liquid-crystal alignment film and liquid-crystal display device
TW200925183A (en) Liquid crystal alignment agent and liquid crystal display element
TW201006869A (en) Liquid crystal alignment agent and liquid crystal display element
TW201005005A (en) Liquid crystal alignment agent and liquid crystal display element
TW200804937A (en) Liquid crystal alignment agent and liquid crystal display device
TW200832019A (en) Liguid crystal alignment agent and liquid crystal display element
TWI433870B (en) Liquid crystal aligning agent and liquid crystal display element
TWI457667B (en) Liquid crystal alignment agent and liquid crystal display element
TW200811553A (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TW200903116A (en) Liquid crystal aligning agent and liquid crystal display
TWI501011B (en) Liquid crystal aligning agent and liquid crystal display element
TW201005004A (en) Liquid crystal aligning agent, liquid crystal aligning film and liquid crystal display element
TWI444727B (en) Liquid crystal alignment agent and liquid crystal display element
TWI427103B (en) Liquid crystal aligning agent and liquid crystal display element
TWI354843B (en) Liquid crystal alignment agent and liquid crystal
TWI359175B (en)
TWI358006B (en) Liquid crystal alignment agent and liquid crystal
TWI442143B (en) Liquid crystal alignment agent and liquid crystal display element
TWI442144B (en) Liquid crystal alignment agent and liquid crystal display element
TWI428370B (en) Liquid crystal aligning agent and liquid crystal display element
TW200804519A (en) Liquid crystal alignment agent for ink-jet coating and liquid crystal display device
TWI466921B (en) Vertical alignment type liquid crystal aligning agent and vertical alignment type liquid crystal display element